UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington D.C. 20549

SCHEDULE 14A INFORMATION

Proxy Statement Pursuant to Section 14(a) of the

Securities Exchange Act of 1934

Filed by the registrant    þ

Filed by a party other than the registrant    ☐

Check the appropriate box:

☐    Preliminary Proxy Statement

☐    Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

þ    Definitive Proxy Statement

☐    Definitive Additional Materials

☐    Soliciting Material Pursuant to §240.14a-12

IZEA Worldwide, Inc.

(Name of Registrant as Specified In Its Charter)

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check the appropriate box):

þ    No fee required

☐    Fee paid previously with preliminary materials

☐    Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11

NOTICE OF ANNUAL MEETING TO BE HELD ON DECEMBER 12, 2024

Dear Stockholder:

    We cordially invite you to attend the 2024 annual meeting of stockholders (the “Annual Meeting”) of IZEA Worldwide, Inc. (“IZEA,” “we,” “us” or “our”), which will be held on Thursday, December 12, 2024 at 4:30 p.m., local time, at Hyatt Regency Orlando International Airport. We have scheduled the Annual Meeting to:

•elect the seven nominees to the Board of Directors nominated by the Board of Directors;

•approve an amendment to IZEA’s Amended and Restated 2011 Equity Incentive Plan to, among other things, increase the number of shares of common stock authorized for issuance thereunder by 700,000.

•ratify the appointment of Grant Thornton LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024;

•approve, on a non-binding advisory basis, the compensation paid to IZEA’s named executive officers (commonly known as “say-on-pay”); and

•transact such other business as may properly come before the Annual Meeting and any adjournments or postponements thereof.

    The accompanying proxy statement sets forth additional information regarding the Annual Meeting and provides you with detailed information regarding the business to be considered at the Annual Meeting. We encourage you to read the proxy statement carefully and in its entirety.

    Only stockholders of record at the close of business on October 15, 2024, the record date fixed by the Board of Directors, are entitled to notice of and to vote at the Annual Meeting and any adjournments or postponements thereof.

    YOUR VOTE IS VERY IMPORTANT. Regardless of whether you plan to attend the Annual Meeting, we ask that you promptly cast your vote via telephone or the internet following the instructions provided in the Notice of Internet Availability of Proxy Materials. We encourage you to vote via the internet, because we believe doing so provides the most convenient option for our stockholders, lowers the cost of our annual meeting and conserves natural resources.

	By order of the Board of Directors:
	Patrick J. Venetucci
October 29, 2024	Chief Executive Officer

Important Notice Regarding the Availability of Proxy Materials for the Annual Meeting

    Our proxy statement follows, and our Annual Report on Form 10-K contains financial and other information regarding IZEA. You may find the proxy statement and our Annual Report on Form 10-K for the year ended December 31, 2023 at www.izea.com/investor-relations/sec-filings.

 

Table of Contents	Page
Questions and Answers About These Proxy Materials and Voting	1
Proposals to be Submitted for Voting
Proposal 1: Election of Directors	5
Proposal 2: Approval of an Amendment to IZEA’s Amended and Restated 2011 Equity Incentive Plan	8
Proposal 3: Ratification of Appointment of External Auditor	12
Proposal 4: Approval of an Advisory Proposal on Executive Compensation	12
Security Ownership of Certain Beneficial Owners and Management	13
Corporate Governance
Director Independence	14
Board and Committee Meetings	15
Board Committees	15
Board Leadership Structure	17
Board Role in Risk Oversight	17
Code of Business Conduct and Ethics	17
Anti-Hedging and Pledging Policies	17
Stockholder Recommendations for Board Candidates	17
Stockholder Communications with the Board	18
Audit Committee Report	19
Executive Officers	20
Executive and Director Compensation	20
Summary Compensation Table	20
Employment Agreements	21
Outstanding Equity Awards at Fiscal Year End	25
Equity Incentive Plans	28
Pay Versus Performance	29
Director Compensation	33
Certain Relationships and Related Transactions	34
Householding of Proxy Materials	34
Stockholder Proposals and Nominations	35
Delinquent Section 16(A) Reports	36
Other Business	36

IZEA Worldwide, Inc.

PROXY STATEMENT

FOR

2024 ANNUAL MEETING OF STOCKHOLDERS

    The Board of Directors (the “Board”) of IZEA Worldwide, Inc. (“the Company,” “IZEA,” “we,” “us,” or “our”), having its principal location at 1317 Edgewater Drive, #1880, Orlando, Florida 32804, is providing these proxy materials to you in connection with IZEA’s 2024 annual meeting of stockholders (the “Annual Meeting”). The Annual Meeting will be held on Thursday, December 12, 2024 at 4:30 p.m., local time, at the Hyatt Regency Orlando International Airport. This proxy statement and the accompanying notice and form of proxy are being made available to stockholders on or about October 29, 2024. This proxy statement contains important information for you to consider when deciding how to vote on the matters brought before the Annual Meeting.

QUESTIONS AND ANSWERS ABOUT THESE PROXY MATERIALS AND VOTING

Q:    Why did I receive a notice as to the Internet availability of proxy materials instead of a full set of materials?

A:    Pursuant to rules adopted by the Securities and Exchange Commission (“SEC”), we have elected to provide access to our proxy materials over the Internet. We have sent a Notice of Internet Availability of Proxy Materials, together with a proxy card, to our stockholders of record as of October 15, 2024. Instructions on how to access proxy materials over the Internet or to request a printed copy may be found in the Notice of Internet Availability. In addition, you may request to receive future proxy materials in printed form by mail or electronically. Your election to receive future proxy materials by mail or electronically will remain in effect until you terminate such election.

Q:    How can I access the proxy materials over the Internet?

A:    You may view and also download our proxy materials for the Annual Meeting, including the Notice of Internet Availability, the Proxy Statement, the form of proxy card, and our 2023 Annual Report to Stockholders, on our website at www.izea.com as well as at www.proxyvote.com.

Q:    How do I attend the Annual Meeting?

A:    The meeting will be held on Thursday, December 12, 2024, at 4:30 p.m., local time, at the Hyatt Regency Orlando International Airport, 9300 Jeff Fuqua Blvd, Orlando, Florida. Directions to the meeting location may be obtained by contacting our Corporate Secretary at 407-985-2935.

Q:    Who can vote at the Annual Meeting?

A:    All stockholders of record as of the close of business on October 15, 2024 (the “Record Date”) are entitled to vote at the Annual Meeting. Each share of common stock is entitled to one vote. As of the Record Date, there were 16,944,251 shares of common stock outstanding and entitled to vote at the Annual Meeting. Stockholders do not have cumulative voting rights.

Stockholder of Record: Shares Registered in Your Name

If on the Record Date, your shares were registered directly in your name on the books and records of our transfer agent, Broadridge Financial Solutions, Inc., then you are a stockholder of record. As a stockholder of record, you may vote in person at the meeting or vote by proxy. Whether or not you plan to attend the meeting, we urge you to fill out and return the enclosed proxy card or vote by proxy over the telephone or on the Internet as instructed below, to ensure your vote is counted. Each stockholder may be asked to present valid picture identification such as a driver’s license or passport and proof of stock ownership as of the Record Date.

1

Beneficial Owner: Shares Registered in the Name of a Broker or Bank

If on the Record Date, your shares were held, not in your name, but rather in an account at a brokerage firm, bank, dealer, or similar organization, then you are considered the beneficial owner of shares held in “street name” and are not a stockholder of record. For shares held in street name, the bank, broker, or similar organization is considered to be the stockholder of record for purposes of voting at the Annual Meeting. As a beneficial owner, you have the right to direct your broker or other agent regarding how to vote the shares in your account. You are also invited to attend the Annual Meeting. However, since you are not the stockholder of record, you will not be able to vote your shares in person at the meeting unless you request and obtain a valid proxy from the stockholder of record authorizing you to vote your shares.

Q:    What items will be voted on at the Annual Meeting?

A:    There are four proposals scheduled to be voted on at the Annual Meeting:

•Proposal 1: Election of Directors. The election of the nominees to the Board nominated by our Board of Directors.

•Proposal 2: Amendment to IZEA’s 2011 Amended and Restated 2011 Equity Incentive Plan. The approval of an amendment to IZEA’s Amended and Restated 2011 Equity Incentive Plan to, among other things, increase the number of shares of common stock authorized for issuance thereunder by 700,000.

•Proposal 3: Ratification of Appointment of Independent Registered Public Accounting Firm. The ratification of the Audit Committee’s appointment of Grant Thornton LLP as IZEA’s independent registered public accounting firm for the fiscal year ending December 31, 2024.

•Proposal 4: Non-Binding, Advisory Approval of Executive Compensation (“Say-On-Pay”). The approval, on a non-binding advisory basis, of a proposal regarding the compensation paid to IZEA’s named executive officers.

Q:    What are the Board’s voting recommendations?

A: The Board recommends that you vote your shares:

•FOR the nominees to the Board;

•FOR the amendment to IZEA’s Amended and Restated 2011 Equity Incentive Plan; and

•FOR the ratification of the appointment of Grant Thornton LLP as our independent registered public accounting firm; and

•FOR the approval, on a non-binding, advisory basis, of the compensation paid to our named executive officers.

Q:    What if another matter is properly brought before the meeting?

A:    The Board does not anticipate that any other matters will be presented for consideration at the Annual Meeting. If any other matters are properly raised at the meeting, it is the intention of the persons named in the accompanying proxy to vote on those matters in accordance with their best judgment.

Q:    How do I vote?

A:    With respect to the election of directors, you may either vote “For” all the nominees to the Board or you may "Withhold" your vote for any nominee you specify. With respect to the approval, on a non-binding, advisory basis, of the compensation paid to our named executive officers, the ratification of the appointment of Grant Thornton LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024, and the amendment to the Amended and Restated 2011 Equity Incentive Plan, you may vote “For” or “Against” or abstain from voting.

Stockholder of Record: Shares Registered in Your Name

If you are a stockholder of record, you may vote in person at the Annual Meeting, vote by proxy using the enclosed proxy card, vote by proxy over the telephone, or vote by proxy through the Internet. Whether or not you plan to attend the Annual Meeting, we urge you to vote by proxy to ensure your vote is counted. You may still attend the Annual Meeting and vote in person even if you have already voted by proxy.

2

•In Person. To vote in person, come to the Annual Meeting and we will provide you with a ballot when you arrive.

•By Mail. To vote using the proxy card, simply complete, sign and date the proxy card and return it promptly in the envelope provided. We must receive your signed proxy card by 11:59 p.m. Eastern time on December 11, 2024 to be counted.

•By Telephone. To vote over the telephone from a location in the United States, Canada, or Puerto Rico, dial toll-free 1-800-690-6903 and follow the recorded instructions. You will be asked to provide the company number and control number from the enclosed proxy card. Your vote must be received by 11:59 p.m. Eastern time on December 11, 2024 to be counted.

•Via the Internet. To vote via the Internet, go to www.proxyvote.com to complete an electronic proxy card. You will be asked to provide the company number and control number from the Notice of Internet Availability. Your vote must be received by 11:59 p.m. Eastern time on December 11, 2024 to be counted.

Beneficial Owner: Shares Registered in the Name of Broker or Bank

If you are a beneficial owner of shares registered in the name of your broker, bank, or other agent, you should receive a proxy card and voting instructions with these proxy materials from that organization rather than from us. Simply complete and mail the proxy card to ensure that your vote is counted. Alternatively, you may vote by telephone or over the Internet as instructed by your broker or bank. To vote in person at the Annual Meeting, you must obtain a valid proxy from the stockholder of record authorizing you to vote for your shares. Follow the instructions from your broker or bank included with these proxy materials, or contact your broker or bank, to request a proxy form.

Q:    How many votes do I have?

A:    On each matter, you have one vote for each share of common stock you own as of the Record Date.

Q:    Who is soliciting proxies and who is paying for this proxy solicitation?

A:    We are making, and will bear all expenses incurred in connection with, the solicitation of proxies. In addition to these proxy materials, our directors and employees may also solicit proxies in person, by telephone, or by other means of communication. Directors and employees will not be paid any additional compensation for soliciting proxies. Although we do not currently contemplate doing so, we may engage a proxy solicitation firm to assist us in soliciting proxies, and if we do so we will pay the fees of any such firm.

We request persons such as brokers, nominees, and fiduciaries holding stock in their names for others or holding stock for others who have the right to give voting instructions, to forward proxy materials to their principals, and to request authority for the execution of the proxy. We will reimburse such persons for their reasonable expenses.

Q:    What does it mean if I receive more than one Notice of Internet Availability?

A:    If you receive more than one Notice of Internet Availability, your shares may be registered in more than one name or in different accounts. Please follow the voting instructions on each of the proxy cards in the proxy materials to ensure that all of your shares are voted.

Q:    Can I change or revoke my vote after submitting my proxy?

A:    Yes. You can change or revoke your proxy at any time before the final vote at the Annual Meeting. If you are the record holder of your shares, you may change or revoke your proxy in any one of the following ways:

•You may submit another properly completed proxy card with a later date.

•You may grant a subsequent proxy by telephone or through the Internet.

•You may send a timely written revocation of your proxy to our Corporate Secretary at IZEA Worldwide, Inc. at 1317 Edgewater Drive, #1880, Orlando, Florida 32804.

3

•You may attend the Annual Meeting and vote in person. Simply attending the Annual Meeting will not, by itself, revoke your proxy.

Your most current proxy card or telephone or Internet proxy is the one that is counted. If your shares are held by your broker or bank as a nominee or agent, you should follow the instructions provided by your broker or bank.

Q:    What if I do not specify a choice for a matter when returning a proxy?

A:    Your proxy will be treated as follows:

•Stockholders of record. If you are a stockholder of record and you sign and return a proxy card without giving specific voting instructions, then the proxy holders will vote your shares in the manner recommended by the Board on all matters presented in this proxy statement and as the proxy holders may determine in their discretion for any other matters properly presented for a vote at the meeting.

•Beneficial owners of shares held in “street name.” If you are a beneficial owner of shares held in “street name” and do not provide the organization that holds your shares with specific voting instructions, the organization that holds your shares may generally vote on routine matters but cannot vote on non-routine matters. If the organization that holds your shares does not receive instructions from you on how to vote your shares on a non-routine matter, the organization that holds your shares will inform the inspector of election that it does not have the authority to vote on this matter with respect to your shares. This is referred to as a “broker non-vote.”

Q:    Which ballot measures are considered “routine” or “non-routine”?

A:    The election of directors (Proposal 1), amendment to the Amended and Restated 2011 Equity Incentive Plan (Proposal 2), and the approval, on an advisory basis, of the compensation of our named executive officers (Proposal 4) are considered to be non-routine matters under applicable rules. A broker or other nominee cannot vote without instructions on non-routine matters, so unless the beneficial owner gives the broker or nominee specific instructions regarding the owner’s vote on each proposal, there may be broker non-votes on Proposals 1, 2, and 4.

The ratification of the appointment of Grant Thornton LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024 (Proposal 3) is considered to be a routine matter under applicable rules. A broker or other nominee may generally vote on routine matters, and we do not expect there to be any broker non-votes with respect to Proposal 3.

Q:    How many votes are needed to approve the proposals?

A:    The following votes are needed to approve each proposal:

•For Proposal 1, which relates to the election of directors, the seven nominees receiving a plurality of the affirmative (“FOR”) votes cast will be elected (meaning that the seven director nominees who receive the highest number of shares voted “for” their election are elected).

•Proposal 2, which relates to the approval of an amendment of the Amended and Restated 2011 Equity Incentive Plan, requires the affirmative (“FOR”) vote of a majority of votes cast on the matter (meaning the number of shares voted “for” this proposal must exceed the number of shares voted “against” this proposal).

•Proposal 3, which relates to the ratification of our Audit Committee’s appointment of Grant Thornton LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024, requires the affirmative (“FOR”) vote of a majority of the votes cast on the matter (meaning the number of shares voted “for” this proposal must exceed the number of shares voted “against” this proposal).

•Proposal 4, which relates to the approval, on a non-binding, advisory basis, of the compensation paid to our named executive officers, requires the affirmative (“FOR”) vote of a majority of the votes cast on the matter (meaning the number of shares voted “for” this proposal must exceed the number of shares voted “against” this proposal).

Abstentions and broker non-votes, if any, will not be counted in determining the number of votes cast in connection with any matter presented at the Annual Meeting and will have no impact on any proposal.

There are no dissenters’ rights of appraisal with respect to the matters to be acted upon at the meeting.

4

Q:    What is the quorum requirement for the Annual Meeting?

A:    A quorum of stockholders is necessary to hold a valid meeting. A quorum will be present if stockholders holding at least thirty-three and one-third percent (33 1/3%) of the outstanding shares of stock as of the Record Date are present at the Annual Meeting in person or represented by proxy. On the Record Date, there were 16,944,251 shares outstanding and entitled to vote. Thus, the holders of 5,642,436 shares must be present in person or represented by proxy at the Annual Meeting to have a quorum.

Your shares will be counted towards the quorum only if you submit a valid proxy (or one is submitted on your behalf by your broker, bank, or other nominee) or if you vote in person at the Annual Meeting. Broker non-votes will be counted toward the quorum requirement. If there is no quorum, the holders of a majority of shares present at the meeting in person or represented by proxy may adjourn the Annual Meeting to another date.

Q:    How can I find out the results of the voting at the Annual Meeting?

A:    Preliminary voting results will be announced at the Annual Meeting. Final voting results will be published in Form 8-K within four business days following the Annual Meeting.

PROPOSALS TO BE SUBMITTED FOR VOTING

Proposal 1: Election of Directors

    Upon the recommendation of the Nominations and Corporate Governance Committee of our Board, the Board nominated seven directors for election at the 2024 Annual Meeting to hold office until the next annual meeting of stockholders or until his successor is duly elected and qualified. The seven nominees for election to the Board at the Annual Meeting are: Antonio Bonchristiano, Rodrigo Boscolo, Brian W. Brady, John H. Caron, Lindsay A. Gardner, Daniel R. Rua, and Patrick J. Venetucci.

    Except where authority to vote for directors has been withheld, it is intended that the proxies received pursuant to this solicitation will be voted “FOR” the nominees named below. Our Board of Directors knows of no reason why any nominee would be unable or unwilling to serve, but if such should be the case, proxies will be voted in favor of the remainder of those named and may be voted for substitute nominees in place of those who do not stand. The election of directors will be determined by a plurality of the affirmative (“FOR”) votes cast.

The following table sets forth the nominees to be elected at the 2024 Annual Meeting, the year such director was first elected as a director, and the positions currently held by each director with the Company:

Name	Age	Year First Elected	Position
Antonio Bonchristiano	58	2024	Director
Rodrigo Boscolo	41	2024	Director
Brian W. Brady	66	2012	Director, Nominations & Corporate Governance Committee Chairman
John H. Caron	67	2015	Director, Strategy & Capital Allocation Committee Chairman
Lindsay A. Gardner	64	2013	Chairman of the Board, Audit Committee Chairman
Daniel R. Rua	56	2012	Director, Compensation Committee Chairman
Patrick J. Venetucci	56	2018	Chief Executive Officer and Director

Information Concerning Directors and Nominees for Director

    Set forth below is background information regarding each current director, including the business experience for the past five years (and, in some instances, for prior years) and the additional experience, qualifications, attributes or skills that led the Board to conclude that such director or nominee should serve on the Board.

Antonio Bonchristiano, Director, joined the Company’s Board in September 2024 and was appointed to the Board pursuant to the terms of that certain cooperation agreement (“Cooperation Agreement”) we entered into on September 6, 2024, with GP Cash Management, Ltd., GP Investments, Ltd. (“GP Investments”), Rodrigo Boscolo and Antonio Bonchristiano (collectively with each of their affiliates and controlled associates, the “GP Parties”). Mr. Bonchristiano is the Chief Executive Officer of GP Investments (BVMF: GPIV33), a company focused on private equity, real estate investments and management of funds, since April 2014 and he also serves as Chief Executive Officer of GP-Act III Acquisition Corp. (NASDAQ: GPAT), a $287.5 million blank check company formed for the purpose of effecting a business combination with one or more companies,

5

since March 2021. He joined GP Investments, Ltd. in 1993 and has been a Managing Director since 1995. Prior to joining GP Investments, Ltd. Mr. Bonchristiano was a Partner at Johnston Associates Inc., a finance consultancy based in London, and worked for Salomon Brothers Inc. in London and New York from 1987 to 2000. Currently, Mr. Bonchristiano serves as a member of the board of directors of G2D Investments, Ltd. (2020), a listed investment company (BVMF: G2DI33) focused on high growth, tech and tech-enabled businesses. Mr. Bonchristiano is or was also on the board of several non-profit organizations, including: Fundação Estudar in São Paulo, Brazil (2016), Fundação Bienal de São Paulo (2010-2016) and John Carter Brown Library (Providence, Rhode Island, USA) (2011 to 2020).Previously, Mr. Bonchristiano served as a member of the boards of directors of AMBEV (2014 to 2023) and BR Properties (2018 to 2024), Rimini Street (2017 to 2021), BHG (2010 to 2013), LAHotels (2007 to 2009), ALL (2003 to 2008), CEMAR (2004 to 2005), Gafisa (1997 to 2006), Hopi Hari (2002 to 2007), Submarino (1999 to 2001), Geodex Communication (2001), BRMalls (2005 to 2006), Tempo (2005 to 2006) and Magnesita Refratários (2006 to 2008), among other companies. He was also previously the Chief Financial Officer of SuperMar Supermercados (1995 to 1997) and Founder and Chief Executive Officer of Submarino (1999 to 2001). He was further vice-chairman of the board of directors of BR Properties SA (2012 to 2013), officer of Geodex Communication (1999 to 2000) and Contax Participações (2002 to 2003). Mr. Bonchristiano holds a bachelor’s degree in Politics, Philosophy, and Economics from the University of Oxford.

Rodrigo Boscolo, Director, joined the Company’s Board in September 2024 and was appointed to the Board pursuant to the terms of the Cooperation Agreement. Mr. Boscolo is the Chief Financial Officer of GP Investments and has served in that capacity since 2018. His role encompasses deploying the firm’s proprietary capital in North America and Europe, as well as managing the firm’s global finance, treasury, technology, investor relations and corporate development functions. Since joining GP Investments in 2010, Mr. Boscolo has led or was involved in multiple private equity and capital market transactions in a broad range of geographies and industries, particularly in the technology, business services, consumer and retail sectors. Previously, Mr. Boscolo worked as a consultant at The Boston Consulting Group (2008 to 2010). Currently, Mr. Boscolo currently serves as a member of the boards of directors of G2D Investments, Ltd. (since 2020). He has also served as Chief Financial Officer of GP-Act III Acquisition Corp. since March 2021, and as alternate director at The Craftory, a $550 M global investment house focused exclusively on responsible CPG brands, since 2019. Formerly, Mr. Boscolo served as a member of the boards of directors of Spice Private Equity (2017 to 2023), a Swiss private equity firm, LEON Restaurants (2017 to 2021), a UK-based healthy fast-food chain acquired by EG Group, Magnesita (2014 to 2015), a mining and industrial company that was merged into RHI Magnesita (LSE:RHIM) to create the global leader in refractories, Sascar (2011-2012), a real-time vehicle monitoring and telematics technology company acquired by Michelin (ENXTPA:ML) and Allis (2010-2012), a retail execution and marketing intelligence company acquired by GPS Group (BVMF: GGPS3). Mr. Boscolo is a graduate of the University of Pennsylvania, where he earned an M.B.A. from the Wharton School in 2014 and a M.A. in International Studies from the School of Arts and Sciences at the Lauder Institute in 2016. Rodrigo also holds a M.S. from Kedge Business School, in Marseille, France (2007) and a bachelor’s degree from the University of Sao Paulo (2007).

Brian W. Brady, Director, Nominations & Corporate Governance Committee Chairman, joined the Company’s Board in August 2012. From 1995 to December 2019, Mr. Brady was the President and Chief Executive Officer of Northwest Broadcasting, Inc., and Chairman of Bryson Holdings LLC. Collectively, these companies owned and operated 15 television stations in nine markets. Mr. Brady currently serves on the board of Duration Media, a proprietary digital ad impression technology product, Syncbak, a privately held technology company, and Cox Media Group, a broadcasting and media production company, and Blok Sports/Sparx, an AI backed sports betting technology company. Mr. Brady is also one of three senior advisors for Manhattan West Asset Management, an independent wealth management and high net worth financial advisory firm. Mr. Brady previously served on the FOX Affiliate Board for nine years, serving as Chairman for four of those years. He also previously served on the board of the National Association of Broadcasting (8 years), Saga Communication (9 years) and the Ferris State College Foundation Board (7 years). Mr. Brady holds a Bachelor of Science degree in advertising from Ferris State University. Mr. Brady brings to the Company’s Board more than 25 years of experience in the multi-media industry, making his input invaluable to us as we seek to expand our portfolio of customers and platform offerings.

John H. Caron, Director, Strategy & Capital Allocation Committee Chairman, joined the Company’s Board in April 2015. Mr. Caron has 30+ years of marketing experience in the consumer-packaged goods and restaurant industries. Since May 2017, Mr. Caron has served as Vice President and a director of Entrepreneurs in Action, Inc., a Florida benefit corporation, which, among other things, will be the Manager of one or more funds to invest in early-stage and start-up social enterprises. Mr. Caron has also served as an independent director on the board of Tijuana Flats from November 2015 until April 2024, sits on the board of Thrive Frozen Nutrition, Inc. since April 2014, and previously served on the board of venVelo, a Central Florida early-stage venture fund, since May 2013. Prior to joining the Company’s Board, Mr. Caron was a member of the Company’s Strategic Advisory Board since June 2013. Mr. Caron served as the President of Olive Garden at Darden Restaurants Inc. from May 2011 to January 2013, Darden’s Chief Marketing Officer from March 2010 to May 2011 and Darden’s Executive Vice President of Marketing for Olive Garden from 2003 to 2010. Before joining Darden Restaurants, Mr. Caron served as Vice President and General Manager of Lipton Beverages for Unilever Bestfoods North America from 2000 to 2002. Mr. Caron received a Bachelor of Science degree in Political Science from The Colorado College and a Master’s degree in American

6

Politics from New York University Department of Politics. Mr. Caron also earned a Master’s in Business Administration in Marketing from New York University Stern School of Business. Mr. Caron’s decades of experience in leading and managing marketing and branding operations in highly competitive industries position him well to serve on the Company’s Board.

Lindsay A. Gardner, Chairman of the Board, and Audit Committee Chairman, joined the Company’s Board in December 2013. Mr. Gardner has 30 years of executive management and leadership experience at companies ranging from technology startups to the world’s largest media and entertainment companies. Mr. Gardner is a Co-Founder and Chief Commercial Officer of TokenForm, a SAS startup providing multi-factor authentication to physical documents. Mr. Gardner is also Director and former CEO of Soofa, an outdoor advertising and smart city communication platform, operating its innovative solar-powered digital kiosks in 17 states. Until August 2020, Mr. Gardner served as Senior Vice President and Chief Content Officer of T-Mobile, the nation’s second-largest wireless company, where he spearheaded the company’s entry into video. Previously, he was the Chief Content Officer of Layer3TV, the first new cable operator to launch in the U.S. in a decade. Mr. Gardner joined Layer3TV in January 2015 and led its commercial launch and subsequent sale to T-Mobile. Prior to that, Mr. Gardner was a Senior Advisor to Oaktree Capital Management, a Los Angeles-based private equity firm with $193 billion under management where, beginning in May 2010, he focused on global buyout opportunities in the media sector. From 1999 until mid-2007, Mr. Gardner was Fox Networks’ President, Distribution. Mr. Gardner received an MBA from The Wharton School of the University of Pennsylvania and a Bachelor of Arts degree in Economics from Brandeis University. Mr. Gardner was elected to serve as a member of the Board due to his significant experience in the media, technology, and entertainment industries, as both an executive and a private equity investor.

Daniel R. Rua, Director, Compensation Committee Chairman, rejoined the Company’s Board in July 2012. Since November 2015, Mr. Rua has served as the Chief Executive Officer of Admiral, a private SaaS company that provides visitor relationship management and marketing automation for digital publishers. From September 2006 to May 2011, Mr. Rua served as the Executive Chairman and an early investor in the Company’s predecessor entity IZEA Innovations, Inc. Mr. Rua has been a Managing Partner of Inflexion Partners, an early-stage venture capital fund since January 2002. Prior to Inflexion, Mr. Rua was a Partner with Draper Atlantic, the east coast fund of Silicon Valley’s early-stage venture firm Draper Fisher Jurvetson, from 1999 to 2002. Prior to Draper Atlantic, Mr. Rua led Internet protocol development at IBM’s Networking Labs in the Research Triangle, from 1991 to 1999. Mr. Rua is a former director of InphoMatch (acquired by Sybase) and AuctionRover (acquired by Overture/Yahoo). Mr. Rua holds a Bachelor of Science degree in computer engineering from the University of Florida. He also earned a Juris Doctor from the University of North Carolina School of Law and a Master’s in Business Administration from the Kenan-Flagler Business School of the University of North Carolina. Mr. Rua’s extensive knowledge of the Company’s products and services as a director and early investor in the Company’s predecessor, as well as his many years of experience in venture capital investing and operational leadership of other technology growth companies, position him well to serve on the Company’s Board.

Patrick J. Venetucci, Director, joined the Company’s Board in December 2018. Mr. Venetucci became Chief Executive Officer of IZEA Worldwide on September 6, 2024. From 2018 to 2024, Mr. Venetucci was Chief Executive Officer of MERGE, a private equity-backed company that merges creative, technology and media solutions for clients in the health, financial services, and consumer industries. From 2016 to 2018, Mr. Venetucci was the President of USA Operations and Integration for Dentsu Aegis Network, one of the largest holding companies in the advertising industry. In 2013, Mr. Venetucci founded the MobileAngelo Group, a technology investment and consulting firm, where he initiated a global mobile roll-up capitalized by private equity and other ventures in technology that enable digital transformation and served as its Chief Executive Officer until 2016. From 1990 to 2013, Mr. Venetucci worked for Leo Burnett Worldwide, a global advertising network, serving as its President of Global Operations from 2009 to 2013. In this capacity, he was responsible for growing large global accounts and leading global corporate functions such as corporate strategy, Mergers and Acquisitions, enterprise technology, internal audit, procurement, and production. Before this, Mr. Venetucci was Leo Burnett’s Global Head of Human Resources, where he chaired the executive compensation committee. Earlier in his career at Leo Burnett, he spent over a decade developing fully integrated marketing campaigns for several Fortune 500 clients, and worked at Leo Burnett Tokyo for three years, where he started the company’s first digital marketing service. Mr. Venetucci has served as an advisor to several innovative public and private technology companies, including Solstice Mobile, Signal, ParqEx, and Quiver, as well as to private equity firms. Mr. Venetucci has a Master’s in Business Administration in Finance and in Marketing and Entrepreneurship from the University of Chicago and a Bachelor of Arts in Communications Studies from the University of Iowa. Mr. Venetucci’s extensive knowledge of the advertising industry, as well as knowledge of financial and operational issues, positions him well to serve on the Company’s Board.

Vote Required

The seven nominees receiving a plurality of the affirmative (“FOR”) votes cast will be elected to the Board (meaning that the seven director nominees who receive the highest number of shares voted “for” their election are elected). “Withhold”

7

votes and broker non-votes are not considered votes cast for the foregoing purpose and will have no effect on the election of the nominees.

Recommendation of the Board

THE BOARD UNANIMOUSLY RECOMMENDS A VOTE “FOR” THE ELECTION OF EACH OF ITS NOMINEES TO THE BOARD TO SERVE UNTIL THE 2025 ANNUAL MEETING OF STOCKHOLDERS AND UNTIL THEIR SUCCESSORS ARE DULY ELECTED AND QUALIFIED.

Proposal 2: Approval of an Amendment to IZEA’s Amended and Restated 2011 Equity Incentive Plan

Upon the recommendation of the Compensation Committee, the Board has unanimously approved the amendment to IZEA’s Amended and Restated 2011 Equity Incentive Plan, as amended and restated in 2023 (as so approved, the “2011 Plan”), subject to the approval of the shareholders of the Company. The Board is seeking stockholder approval of the amendment of the 2011 Plan which would increase the number of shares of common stock that are authorized and reserved for issuance under the 2011 Plan by 700,000 shares, from 3,675,000 to 4,375,000 shares (subject to adjustment for stock splits, stock dividends and similar events).

Reasons for Amendment and Restatement of the 2011 Plan

As of October 15, 2024, we had 368,459 shares of common stock available for future grants under the 2011 Plan. The Board believes that an adequate reserve of shares available for issuance under the 2011 Plan is necessary to enable IZEA to attract, motivate, and retain key employees and consultants through competitive incentives tied to stockholder value as it implements it future growth plans. The Board believes the additional shares requested as part of the proposed 2011 Plan, based on historical and expected future grant practices, can be expected to last approximately one year.

Summary of the 2011 Plan, as Proposed to be Amended

The principal features of the 2011 Plan are summarized below. The following summary of the 2011 Plan does not purport to be a complete description of all of the provisions of the 2011 Plan. It is qualified in its entirety by reference to the complete text of the 2011 Plan.

Number of Authorized Shares and Share Counting. Under the 2011 Plan, as amended and restated in 2020, stockholders authorized an aggregate of up to 1,875,000 shares of our common stock, post reverse stock split on June 16, 2023, to be issued thereunder. If the proposed amendment and restatement of the 2011 Plan is approved by our stockholders, an additional 700,000 shares will be added to this share pool, all of which may be used for incentive stock options. Shares issued under the 2011 Plan may consist of unissued shares, treasury shares or other shares reacquired by us. As of October 15, 2024, the closing sale price of a share of our common stock reported on the Nasdaq Stock Market was $2.52.

Should an award expire or be canceled prior to its exercise or vesting in full, the shares of stock under the award that expire or are canceled may be subject to future awards under the 2011 Plan. Also, restricted stock units that are settled in cash will not count against this share pool. If shares to be delivered upon the exercise or vesting of an award are withheld from an award to cover the purchase price of an option or any required tax withholding obligation of an award, such shares may not be subject to future awards under the 2011 Plan. In the event the Company substitutes equity awards of acquired entities in connection with mergers, reorganizations, separations, or other transactions to which Section 424(a) of the Internal Revenue Code of 1986, as amended (the “Code”) applies, the number of shares reserved pursuant to the 2011 Plan will be increased by the number of shares underlying each such substituted awards as of the effectiveness of the substitution.

Administration. The 2011 Plan is administered by the Compensation Committee of the Board (the “Committee”). Subject to the provisions of the 2011 Plan, the Committee has full and final authority, in its discretion, to make awards under the 2011 Plan and to determine the individuals to whom each award is made and the number of shares covered thereby. Subject to the provisions of the 2011 Plan, the Committee also has the power to interpret the 2011 Plan and to prescribe such rules, regulations and procedures in connection with the operations of the 2011 Plan as it deems necessary and advisable in its administration of the 2011 Plan.

Eligibility. Awards may be granted under the 2011 Plan to officers, employees, consultants, and advisors of IZEA and its subsidiaries and to non-employee directors of IZEA. Incentive stock options may be granted only to employees of IZEA or its subsidiaries. As of October 15, 2024 approximately 130 individuals were eligible to receive awards under the 2011 Plan, including three executive officers and five non-employee directors.

Director Award Limitations. No non-employee director may be paid, issued, or granted, in any fiscal year, equity awards (including any awards issued under the 2011 Plan) with an aggregate value ( the value of which will be based on their grant date fair value determined in accordance with U.S. generally accepted accounting principles) and any other compensation

8

(including without limitation any cash retainers or fees) that, in the aggregate, exceed $200,000, increased to $300,000 for such director for the fiscal year in which he or she joins the Board. Any awards or other compensation paid or provided to an individual for his or her services as an employee, or for his or her services as a consultant (other than as a non-employee director), will not count for purposes of the limitation under the 2011 Plan.

Minimum Vesting. Unless otherwise specified in the 2011 Plan, no portion of an award (other than (1) substitute awards, (2) shares delivered in lieu of fully vested cash obligations, and (3) awards to non-employee directors that vest on the earlier of the one year anniversary of the date of grant or the next annual meeting of stockholders which is at least 50 weeks after the immediately preceding year’s annual meeting) will vest earlier than the one-year anniversary of such award’s grant date; provided that awards may be granted without regard to the minimum vesting requirements set forth in the preceding sentence if the shares subject to such awards would not result in more than 5% of the maximum aggregate number of shares authorized for grant under the 2011 Plan. The foregoing vesting criteria will not prevent accelerated vesting of any portion of an award earlier than the one-year anniversary of such award’s grant date if such acceleration is due to a separation from service of the relevant participant or if such acceleration is in connection with a “change in control” (as defined in the 2011 Plan), in each case to the extent otherwise permitted under the Plan.

Types of Awards. The 2011 Plan permits the granting of any or all of the following types of awards:

•Stock Options. Stock options entitle the holder to purchase a specified number of shares of common stock at a specified price (the exercise price), subject to the terms and conditions of the stock option grant. The Committee may grant either incentive stock options, which must comply with Section 422 of the Code, or non-qualified stock options. The Committee sets exercise prices and terms, except that incentive stock options must be granted with an exercise price not less than 100% of the fair market value of the common stock on the date of grant (or 110% for optionees who own more than 10% of the total combined voting power of all classes of stock of the Company or of any subsidiary at the time of grant of the incentive stock option). Unless the Committee determines otherwise, fair market value generally means, as of the grant date, the closing price of the common stock. At the time of grant, the Committee determines the terms and conditions of stock options, including the quantity, exercise price, vesting periods, term (provided no option may be exercisable more than ten years after the date of grant or, in the case of an incentive stock option granted to an optionee who, at the time such incentive stock option is granted, owns more than 10% of the total combined voting power of all classes of stock of the Company or of any subsidiary, more than five years after the date of grant of such incentive stock option) and other conditions on exercise. The 2011 Plan specifies certain default vesting provisions that will apply in the absence of a different determination by the Committee. In connection with certain terminations of a participant’s employment with the Company, the Committee, at its discretion, may accelerate vesting of such a participant’s option at or after grant. An optionee will not have the right to dividends and other rights of a shareholder with respect to shares purchased upon exercise of an option until such time as the optionee (1) has given written notice of exercise and has paid in full for such shares, and (2) has satisfied such conditions that may be imposed by the Company with respect to the withholding of taxes.

•Restricted Stock. The Committee may grant awards of restricted stock, which are shares of common stock subject to specified restrictions. These awards may be made subject to repurchase, forfeiture or vesting restrictions at the Committee’s discretion. The restrictions may be based on continuous service with IZEA or the attainment of specified performance goals, as determined by the Committee. A grantee will have the rights of a stockholder with respect to restricted stock subject to the 2011 Plan. Distributions in the form of dividends or otherwise of additional shares or property in respect of shares of restricted stock will be subject to the same restrictions as such shares of restricted stock. The Committee will determine the treatment of awards upon a grantee’s termination of service with the Company as set forth in the applicable award agreement, and the Committee may determine on or after grant to waive, in whole or in part, any vesting or other conditions with respect to an award.

•Restricted Stock Units (“RSUs”). The Committee may grant awards of RSUs, which are bookkeeping entries representing the equivalent number of shares of stock and are settled either (i) by the delivery of one share of stock for each vested and payable RSU or (ii) in cash in an amount equal to the fair market value of one share of stock for each vested and payable RSU, all as specified in the applicable award agreement. These awards may be made subject to forfeiture or vesting restrictions at the Committee’s discretion. The restrictions may be based on continuous service with IZEA or the attainment of specified performance goals, as determined by the Committee. Grantees do not have voting or dividend rights under RSUs, unless and until shares of stock are delivered in settlement of the award. RSUs may include, however, dividend equivalent rights that may be accrued and paid in cash or additional RSUs at the time, and to the extent, the underlying RSUs vest and become payable. Distributions in the form of dividends or otherwise of additional shares or property in respect to RSUs will be subject to the same restriction as the RSUs to which they relate. The Committee will determine the treatment of awards upon a grantee’s termination of service with the Company as set forth in the applicable award agreement, and the Committee may determine on or after grant to waive, in whole or in part, any vesting or other conditions with respect to an award.

9

Unless the Committee, in its discretion, otherwise determines, no award granted under the 2011 Plan is transferable other than by will or by the laws of descent and distribution, and a stock option may be exercised during a participant’s lifetime only by the participant.

No Repricing without Stockholder Approval. The Committee may not institute an exchange program (including repricing options) without stockholder approval. For this purpose, an exchange program means a program under which (1) outstanding awards are surrendered or cancelled in exchange for awards of the same type (which may have higher or lower exercise prices and different terms), awards of a different type, and/or cash, (2) participants would have the opportunity to transfer any outstanding awards to a financial institution or other person or entity selected by the Committee, and/or (3) the exercise price of an outstanding award is reduced.

Adjustments. If certain changes in the common stock occur by reason of any merger, reorganization, consolidation, recapitalization, stock dividend, or other change in corporate structure affecting the stock, the Committee will make an appropriate and equitable adjustment in (1) the number and kind of shares reserved for issuance under the 2011 Plan and (2) in the number and kind and, if applicable, option price of shares subject to outstanding options and other awards granted under the 2011 Plan. The Committee will, to the extent feasible, make such other adjustments as may be required under the tax laws so that any incentive stock options previously granted will not be deemed modified within the meaning of Section 424(h) of the Code. Appropriate adjustments will also be made in the case of outstanding restricted stock and RSUs granted under the 2011 Plan.

Change in Control. Upon the occurrence of a change in control, the Committee may in its discretion determine to accelerate the vesting, and in the case of the options the exercisability, of any outstanding awards, and with respect to outstanding options, may determine to cancel such options in exchange for a payment equal to the excess (if any) of the fair market value of the stock immediately before the change in control over the exercise price.

Term, Termination and Amendment of the 2011 Plan. Unless earlier terminated by the Board, the 2011 Plan will terminate, and no further awards may be granted after the date 10 years following the effective date of stockholder approval of the amendment and restatement of the 2011 Plan at the Annual Meeting. The Board may amend, suspend or terminate the Plan, except that no amendment will be made that would materially impair the rights of any participant under any award theretofore granted without the participant’s consent, and except that no amendment will be without the approval of the stockholders of the Company to the extent required under applicable laws.

Federal Income Tax Consequences

The following is a brief summary of the U.S. federal income tax consequences of the 2011 Plan generally applicable to IZEA and to participants in the 2011 Plan who are subject to U.S. federal taxes. The summary is based on the Internal Revenue Code, applicable Treasury Regulations, and administrative and judicial interpretations thereof, each as in effect on the date of this proxy statement, and is, therefore, subject to future changes in the law, possibly with retroactive effect. The summary is general in nature and does not purport to be legal or tax advice. Furthermore, the summary does not address issues relating to any U.S. gift or estate tax consequences or the consequences of any state, local or foreign tax laws.

Nonqualified Stock Options. A participant generally will not recognize taxable income upon the grant or vesting of a nonqualified stock option with an exercise price at least equal to the fair market value of our common stock on the date of grant and no additional deferral feature. Upon the exercise of a nonqualified stock option, a participant generally will recognize compensation taxable as ordinary income in an amount equal to the difference between the fair market value of the shares underlying the stock option on the date of exercise and the exercise price of the stock option. When a participant sells the shares, the participant will have short-term or long-term capital gain or loss, as the case may be, equal to the difference between the amount the participant received from the sale and the tax basis of the shares sold. The tax basis of the shares generally will be equal to the greater of the fair market value of the shares on the exercise date or the exercise price of the stock option.

Incentive Stock Options. A participant generally will not recognize taxable income upon the grant of an incentive stock option. If a participant exercises an incentive stock option during employment or within three months after employment ends (12 months in the case of permanent and total disability), the participant will not recognize taxable income at the time of exercise for regular U.S. federal income tax purposes (although the participant generally will have taxable income for alternative minimum tax purposes at that time). If a participant sells or otherwise disposes of the shares acquired upon exercise of an incentive stock option after the later of (a) one year from the date the participant exercised the option and (b) two years from the grant date of the stock option, the participant generally will recognize long-term capital gain or loss equal to the difference between the amount the participant received in the disposition and the exercise price of the stock option. If a participant sells or otherwise disposes of shares acquired upon exercise of an incentive stock option before these holding period requirements are satisfied, the disposition will constitute a “disqualifying disposition,” and the participant generally will recognize taxable ordinary income in the year of disposition equal to the excess of the fair market value of the shares on the date of exercise over the exercise price of the stock option (or, if less, the excess of the amount realized on the disposition of the

10

shares over the exercise price of the stock option). The balance of the participant’s gain on a disqualifying disposition, if any, will be taxed as short-term or long-term capital gain, as the case may be.

With respect to both nonqualified stock options and incentive stock options, special rules apply if a participant uses shares of common stock already held by the participant to pay the exercise price or if the shares received upon exercise of the stock option are subject to a substantial risk of forfeiture by the participant.

Restricted Stock and RSU Awards. A participant generally will not have taxable income upon the grant of restricted stock or RSUs. Instead, the participant will recognize ordinary income at the time of vesting or payout equal to the fair market value (on the vesting or payout date) of the shares or cash received minus any amount paid. For restricted stock only, a participant may instead elect to be taxed at the time of grant in accordance with Section 83(b) of the Internal Revenue Code.

Tax Consequences to IZEA. In the foregoing cases, we generally will be entitled to a deduction at the same time, and in the same amount, as a participant recognizes ordinary income, subject to certain limitations imposed under the Internal Revenue Code such as Section 162(m).

Tax Withholding. We are authorized to deduct or withhold from any award granted or payment due under the Amended Plan, or require a participant to remit to us, the amount of any withholding taxes due in respect of the award or payment and to take such other action as may be necessary to satisfy all obligations for the payment of applicable withholding taxes. We are not required to issue any shares of common stock or otherwise settle an award under the 2011 Plan until all tax withholding obligations are satisfied.

New Plan Benefits

The exact types and amounts of any future awards to be made to any eligible participants pursuant to the 2011 Plan are not presently determinable. As a result of the discretionary nature of the 2011 Plan, it is not possible to state who the participants in the 2011 Plan will be in the future or the number of options or other awards to be received by a person or group.

2011 Plan Benefits

For each of the individuals and groups indicated, the total number of shares of our common stock subject to all stock awards that have been granted (even if not currently outstanding) under the 2011 Plan since inception through the Record Date, is as follows:

Name	Shares
Edward H. (Ted) Murphy, Chief Executive Officer, Director (Separation Effective 9/15/24)	549,413
Ryan S. Schram, President, Chief Operating Officer, Director (Separation Effective 9/15/24)	82,848
Peter J. Biere, Chief Financial Officer	159,713
All current executive officers as a group	791,974
All current directors who are not executive officers as a group	1,160,912
Each nominee for election as a director	613,128
Each associate of any director, executive officer or nominee for election as a director;	—
Each other person who received or is to receive 5 percent of such options, warrants or rights; and	939,929
All current and former employees, including all current officers who are not executive officers, as a group	2,892,815

Vote Required

The approval of the amendment to the 2011 Plan requires the affirmative (“FOR”) vote of a majority of the total votes cast on the proposal at the Annual Meeting, either in person or by proxy. Abstentions and broker non-votes are not considered votes cast on the foregoing proposal and will have no effect on the outcome of the proposal.

Recommendation of the Board

THE BOARD UNANIMOUSLY RECOMMENDS A VOTE “FOR” THE APPROVAL OF THE AMENDMENT TO IZEA’S 2011 AMENDED AND RESTATED EQUITY INCENTIVE PLAN.

11

Proposal 3: Ratification of Appointment of Independent Registered Public Accounting Firm

The Audit Committee of the Board has appointed Grant Thornton LLP (“GT”) as our independent registered public accounting firm for the fiscal year ending December 31, 2024. We are presenting this selection to our stockholders for ratification at the annual meeting.

A representative of GT is expected to be present at the Annual Meeting. In addition to having an opportunity to make a statement, the GT representative will be available to respond to any appropriate questions.

    In the event that stockholders fail to ratify the appointment of GT, the Audit Committee will take such action into account in reconsidering the appointment of GT for 2024. Even if the appointment is ratified, the ratification is not binding and the Audit Committee may, in its discretion, direct the appointment of a different independent registered public accounting firm at any time during the year.

Pre-Approval Policies and Procedures

The Audit Committee has adopted a policy that requires that all services to be provided by the Company’s independent public accounting firm, including auditing services, and permitted non-audit services, be pre-approved by the Audit Committee, subject to the de minimis exceptions for non-audit services described in Section 10A(i)(1)(B) of the Exchange Act, which nonetheless the Board endeavors to approve prior to the completion of the audit. The Audit Committee approved all audit and permitted non-audit services provided by GT during 2023 and 2022.

The following table presents the aggregate fees billed by GT for audit and non-audit services, rendered in 2023 and 2022, including “out-of-pocket” expenses incurred in rendering these services. The nature of the services provided for each category is described following the table:

	Twelve Months Ended December 31,
Fee Category	2023		2022
Audit Fees (1)	$	671,140	$	646,937
Total	$	671,140	$	646,937

_______________

(1)“Audit Fees” means the aggregate fees billed by the principal accountant for each of the last two fiscal years for professional service rendered for the audit and review of financial statements.

Vote Required

Ratification of the appointment of GT as our independent registered public accounting firm for the fiscal year ending December 31, 2024 requires the affirmative (“FOR”) vote of a majority of the votes cast on the matter (meaning the number of shares voted “for” this proposal must exceed the number of shares voted “against” this proposal). Abstentions and broker non-votes, to the extent there are any such broker non-votes, are not considered votes cast on the foregoing proposal, and will have no effect on the outcome of this proposal.

Recommendation of the Board

THE BOARD UNANIMOUSLY RECOMMENDS A VOTE “FOR” THE RATIFICATION OF THE APPOINTMENT OF GRANT THORNTON LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2024.

Proposal 4: Non-Binding, Advisory Approval of Executive Compensation

This Proposal 4 enables our stockholders to cast a non-binding, advisory vote to approve the compensation of our named executive officers as disclosed in this proxy statement as required by Section 14A of the Exchange Act.

The Board is committed to excellence in governance and is aware of the significant interest in executive compensation matters by investors and the general public.

Our executive compensation program is designed to attract, motivate, reward, and retain the senior management talent required to achieve our corporate objectives and increase stockholder value. We believe that our compensation programs are centered on pay-for-performance principles and are strongly aligned with the long-term interests of our stockholders. Please read the “Executive Compensation” section for additional details about our executive compensation programs, including information about the compensation of our named executive officers.

12

We are providing our stockholders with the opportunity to express their views on our named executive officers’ compensation by casting their vote on this Proposal 4. This non-binding, advisory vote is not intended to address any specific item of compensation, but rather the overall compensation of our named executive officers and the philosophy, policies and practices described in this proxy statement. We currently hold this non-binding, advisory vote to approve the compensation of our named executive officers every year.

Accordingly, we are asking stockholders to vote “FOR” the following resolution at the Annual Meeting:

“RESOLVED, that the stockholders approve the compensation paid to IZEA’s named executive officers, as described in the executive compensation tables and accompanying narrative discussion in the Proxy Statement.”

Although the vote on this Proposal 4 regarding the compensation of our named executive officers is not binding on our Board, we value the opinions of our stockholders and will consider the result of the vote when determining future executive compensation arrangements. We currently hold our Say on Pay vote annually.

Vote Required

The approval, on an advisory basis, of the foregoing resolution regarding the compensation of our named executive officers requires the affirmative (“FOR”) vote of a majority of the total votes cast on the proposal at the Annual Meeting, either in person or by proxy. Abstentions and broker non-votes are not considered votes cast on the foregoing proposal and will have no effect on the outcome of this proposal.

Recommendation of the Board

THE BOARD UNANIMOUSLY RECOMMENDS A VOTE “FOR” THE APPROVAL, ON AN ADVISORY BASIS, OF THE COMPENSATION PAID TO IZEA’S NAMED EXECUTIVE OFFICERS AS DISCLOSED IN THIS PROXY STATEMENT.

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

    The following table presents information with respect to the beneficial ownership of our common stock as of October 15, 2024 by:

•each person or group of affiliated persons, known to us to beneficially own more than 5% of our outstanding common stock (“5% holders”);

•each of our directors and named executive officers; and,

•all of our directors and executive officers as a group.

    The number of shares of our common stock owned by each person is determined under the rules of the SEC. Under these rules, beneficial ownership includes any shares as to which the individual has sole or shared voting power or investment power and also any shares that the individual has the right to acquire within 60 days after October 15, 2024, or by December 14, 2024, through the conversion of a security or other right. Shares not outstanding but deemed beneficially owned by virtue of the right of a person to acquire those shares are treated as outstanding only for purposes of determining the number and percent of shares of common stock owned by such person or group.

Unless otherwise indicated, we believe that all persons named in the following table have sole voting and investment power with respect to all shares of common stock beneficially owned by them and the address of each person named in the following table is c/o IZEA Worldwide, Inc., 1317 Edgewater Drive, #1880, Orlando, Florida 32804.

13

Name of Beneficial Owner	Shares Beneficially Owned	Percentage of Common Stock Beneficially Owned (1)
Executive Officers and Directors:
Patrick J. Venetucci (2)	104,893	*
Peter J. Biere (3)	34,231	*
Antonio Bonchristiano (4)	1,473	*
Rodrigo Boscolo (5)	1,473	*
Brian W. Brady (6)	432,979	2.6	%
John H. Caron (7)	85,254	*
Lindsay A. Gardner (8)	96,262	*
Daniel R. Rua (9)	69,015	*
Edward H. Murphy(10)	904,453	5.3	%
Ryan S. Schram(11)	148,493	*
All executive officers and directors as a group (8 persons) (12)	825,580	4.9	%
5% Stockholders:
GP Cash Management, Ltd. (13)	3,002,036	17.7	%

_______________

* Less than 1 percent.

(1)Applicable percentage of ownership for each holder is based on 16,922,268 shares outstanding as of October 15, 2024.

(2)Includes 72,993 outstanding shares of common stock, exercisable stock options to purchase 1,250 shares of common stock, and 30,650 restricted stock units expected to vest within 60 days under the 2011 Plan.

(3)Includes 17,419 outstanding shares of common stock, exercisable stock options to purchase 6,366 shares of common stock, and 10,446 restricted stock units expected to vest within 60 days under the 2011 Plan.

(4)Includes 1,473 outstanding shares of common stock.

(5)Includes 1,473 outstanding shares of common stock.

(6)Includes 430,508 outstanding shares of common stock and stock options exercisable for 2,471 shares of common stock under the 2011 Plan.

(7)Includes 84,629 outstanding shares of common stock and stock options exercisable for 625 shares of common stock under the 2011 Plan.

(8)Includes 95,973 outstanding shares of common stock and stock options exercisable for 289 shares of common stock under the 2011 Plan.

(9)Includes 66,773 outstanding shares of common stock and stock options exercisable for 2,242 shares of common stock under the 2011 Plan.

(10)Includes 623,202 outstanding shares of common stock and stock options exercisable for 281,251 shares of common stock under the 2011 Plan.

(11)Includes 126,557 outstanding shares of common stock and stock options exercisable for 21,936 shares of common stock under the 2011 Plan.

(12)For all executive officers and directors as a group, this amount includes 771,241 outstanding shares of common stock, exercisable stock options to purchase 13,243 shares of common stock and 41,096 restricted stock units expected to vest within 60 days of October 15, 2024 under the 2011 Plan as further detailed in footnotes (2) through (9) above.

(13)Based on the Form 4, jointly filed by GP Cash Management, Ltd. (“GP Cash Management”) and GP Investments, Ltd. (“GP Investments”) with the SEC on May 16, 2024. According to the Schedule 13G jointly filed by GP Cash Management and GP Investments with the SEC on March 1, 2024, GP Investments is the sole shareholder of GP Cash Management. Fersen Lambranho and Antonio Bonchristiano, a director of the Company, share voting control over the controlling shareholder of GP Investments. GP Cash Management directly owns 3,002,036 shares of Common Stock. The address of the principal business office of GP Cash Management is Lyford Manor, Western Road, Lyford Cay, Nassau, N.P., The Bahamas, PO BOX CB-13007. The address of the principal business office of GP Investments is 16 Burnaby Street, Hamilton, HM 11, Bermuda.

CORPORATE GOVERNANCE

Director Independence

    The Board has determined that Antonio Bonchristiano, Rodrigo Boscolo, Brian W. Brady, John H. Caron, Lindsay A. Gardner, and Daniel R. Rua are “independent directors” as defined in Nasdaq Listing Rule 5605(a)(2). As provided by the

14

Nasdaq rules, the Board has made a subjective determination as to each independent director that no relationships exist which, in the opinion of the Board, would interfere with the exercise of independent judgment in carrying out the responsibilities of a director. In making these determinations, the Board reviewed and discussed information provided by the directors with regard to each director’s business and personal activities as they may relate to us and our management.

Board and Committee Meetings

During the fiscal year ended December 31, 2023:

•the Board held five meetings,

•the Audit Committee held six meetings;

•the Nominations & Corporate Governance Committee held one meeting; and

•the Compensation Committee held ten meetings.

Each of the directors attended at least 75% of the aggregate of each of (i) the total number of meetings of the Board (held during the period for which he or she served as a director), and (ii) the total number of meetings held by all committees of the Board on which he served (during the periods that he served on such committees). Although we do not have a formal policy regarding director attendance at annual meetings of stockholders, each director is encouraged and expected to attend the Annual Meeting. All seven directors then serving on the Board of Directors attended the 2023 annual meeting of stockholders.

Board Committees

Our Board has four active standing committees to assist it with its responsibilities. Below, we describe the four committees, the charters of which are available on our website at https://izea.com. Neither our website nor its contents are incorporated into this Proxy Statement.

Audit Committee. The Audit Committee’s duties are to recommend to the Board the engagement of independent auditors to audit our financial statements and to review our accounting policies and financial statements. The Audit Committee is responsible for reviewing the scope and fees for the annual audit and the results of audit examinations performed by our independent public accountants, including their recommendations to improve the system of accounting and internal controls. The Audit Committee will at all times be composed exclusively of directors who are, in the opinion of the Board, free from any relationship which would interfere with the exercise of independent judgment as a committee member and who possess an understanding of financial statements and generally accepted accounting principles.

     The Audit Committee is currently comprised of three non-employee directors Lindsay A. Gardner, John H. Caron, and Daniel R. Rua. Mr. Gardner serves as the audit committee chairperson and is designated as the “audit committee financial expert” based on his thirty years of experience in executive management and leadership. The Board has determined that all members of the Audit Committee are “independent” as that term is currently defined in the Nasdaq Listing Rule 5605(a)(2) and Rule 10A-3(b)(1) of the Securities Exchange Act of 1934. The Audit Committee met six times during the year ended December 31, 2023.

Compensation Committee. The Compensation Committee is tasked with reviewing and approving our compensation policies, including compensation of executive officers. The Compensation Committee is also charged with reviewing and administering our equity incentive compensation plans and recommending and approving grants of stock options or other awards under that plan. In accordance with its charter, the Compensation Committee retains the sole authority to select, retain, and/or replace, as needed, any compensation or other outside consultant to be used to assist in the evaluation of director, CEO, or senior executive compensation.

The Compensation Committee is comprised of three non-employee directors, Antonio Bonchristiano, Lindsay A. Gardner, and Daniel R. Rua. Mr. Rua serves as the chairman of the Compensation Committee. The Board has determined that all members of the Compensation Committee are “independent” as that term is currently defined in the Nasdaq Listing Rule 5605(a)(2). The Compensation Committee met ten times during the year ended December 31, 2023. To the extent permitted by the Company’s Bylaws and applicable law, rules, regulations and listing requirements, the Compensation Committee may form and delegate authority to subcommittees of the Compensation Committee.

Nominations and Corporate Governance Committee. The purpose of the Nominations and Corporate Governance Committee is to select, or recommend for our entire Board’s selection, the individuals to stand for election as directors at the annual meeting of stockholders and to oversee the selection and composition of committees of our Board. The Nominations and Corporate Governance Committee’s duties also include considering the adequacy of our corporate governance and overseeing and approving management continuity planning processes. The Nominations and Corporate Governance Committee is comprised of all of three non-employee directors: Brian W. Brady, Antonio Bonchristiano and Daniel R. Rua. The Board has determined that all members of the Nominations and Corporate Governance Committee are “independent” as that term is

15

currently defined in the Nasdaq Listing Rule 5605(a)(2). Mr. Brady serves as the chairman of the Nominations and Corporate Governance Committee. The Nominations and Corporate Governance Committee met telephonically one time during the year ended December 31, 2023.

Strategy and Capital Allocation Committee. The purpose of the Strategy and Capital Allocation Committee is to evaluate and make reports and recommendations on strategic options, sources and uses of capital, capital structure, and cash management. The Strategy and Capital Allocations Committee’s duties also include making recommendations to the Board regarding the company’s financial and capital allocation priorities, long-term planning, and the company’s strategic opportunities, operational improvements, and ways to enhance long-term value. The Strategy and Capital Allocation Committee is comprised of four non-employee directors: Antonio Bonchristiano, Rodrigo Boscolo, John H. Caron, and Lindsay Gardner. The Board has determined that all members of the Strategy and Capital Allocation Committee are “independent” as that term is currently defined in the Nasdaq Listing Rule 5605(a)(2). Mr. Caron serves as the chairman of the Strategy and Capital Allocation Committee.

While we do not have a formal diversity policy for Board membership, the Board does seek to ensure that its membership consists of sufficiently diverse backgrounds, meaning a mix of backgrounds and experiences that will enhance the quality of the Board’s deliberations and decisions. In considering candidates for the Board, the independent directors consider, among other factors, diversity with respect to viewpoints, skills, experience, and other demographics. Additionally, pursuant to the Cooperation Agreement we entered into with the GP Parties, we agreed to direct the Nominations and Corporate Governance Committee to conduct a search for a gender-diverse director candidate.

Board Diversity Matrix

Total Number of Directors		7
Part I: Gender Identity	Female	Male
Directors	0	7
Part II: Demographic Background
Hispanic or Latinx	0	3
White	0	4

To see our Board Diversity Matrix as of August 17, 2023 please see the proxy statement filed with the SEC on September 5, 2023.

Director Qualifications

The Board comprises a diverse group of leaders in their respective fields. The Nominations & Corporate Governance Committee believes that the leadership skills and other experiences of the director nominees listed in each nominee’s biographical information provide us with a diverse range of perspectives and judgment necessary to guide our strategies and monitor their execution.

Family Relationships

There are no family relationships among our executive officers and directors.

Identifying and Evaluating Nominees for Directors

    The Nominations & Corporate Governance Committee utilizes a variety of methods for identifying and evaluating nominees for directors, including those discussed in the “Director Qualifications & Board Diversity” section of this proxy statement. In the event that vacancies on the Board are anticipated, or otherwise arise, the committee will consider various potential candidates for director. Candidates may come to the attention of the committee through current members of the Board, professional search firms, stockholders or other persons. The Nominations & Corporate Governance Committee has from time to time retained third parties to whom a fee is paid to assist in identifying or evaluating potential director nominees.

While we do not have a formal diversity policy for Board membership, the Board does seek to ensure that its membership consists of sufficiently diverse backgrounds, meaning a mix of backgrounds and experiences that will enhance the quality of the Board’s deliberations and decisions. In considering candidates for the Board, the independent directors consider, among other factors, diversity with respect to viewpoints, skills, experience, and other demographics.

Stockholders of record (i) on the record date for an annual meeting of stockholders or a special meeting of stockholders called for the purpose of electing directors and (ii) on the date of giving of property notice of such stockholder’s proposal may propose director candidates for the election to the Board at such annual or special meeting by submitting to the Secretary of the Company, in proper written form, the information required by our Bylaws for stockholder nominations.

16

Pursuant to the Company’s Corporate Governance Guidelines, the Nominations & Corporate Governance Committee will evaluate any candidates recommended by stockholders against the same criteria and pursuant to the same policies and procedures applicable to the evaluation of candidates proposed by directors or management.

Board Leadership Structure

    Patrick J. Venetucci has been our Chief Executive Officer since 2024, and has served as a Director since 2018. In September 2024, the Board determined to split the Chairman and CEO role following the departure of Mr. Murphy, naming Lindsay A. Gardner as Chairman of the Board and Mr. Venetucci, who was previously Chairman of the Audit Committee, became our Chief Executive Officer. We believe that separation of the Chairman and Chief Executive Officer positions encourages objective oversight and candid communications regarding the Company. The Chief Executive Officer is responsible for setting the strategic direction for the Company and the day-to-day leadership and performance of the Company, while the Chairman of the Board serves as a liaison between the Board and management, focuses on Board and governance matters, and presides over meetings of the full Board. The Chairman of the Board is an independent, non-management position. We believe our structure is appropriate given the size and operating philosophy of our organization, as it allows our Chief Executive Officer to focus on the Company’s strategy, business, and operations and allows our Chairman of the Board to provide objective oversight of the Company.

Six of our seven directors are independent within the meaning of SEC and Nasdaq rules. In addition, all of the directors on each of the Audit Committee, Compensation Committee, and Nominations and Corporate Governance Committee are independent and each of these committees is led by an independent committee chair. The committee chairs set the agendas for their committees and report to the full Board on their work. As required by Nasdaq, our independent directors meet in executive session without management present as frequently as they deem appropriate, typically at the time of each regular in-person Board meeting. All of our directors are highly accomplished and experienced business people in their respective fields, who have demonstrated leadership in significant enterprises and are familiar with board processes. Our independent directors bring experience, oversight, and expertise from outside the company and industry, while Mr. Venetucci brings extensive industry-specific experience and value-creation expertise.

Board Role in Risk Oversight

    While the Board is responsible for overseeing our risk management, the Board has delegated many of these functions to the Audit Committee. Under its charter, the Audit Committee is responsible for discussing with management and the independent auditors our major financial risk exposures, the guidelines, and policies by which risk assessment and management is undertaken, and the steps management has taken to monitor and control risk exposure. In addition to the Audit Committee’s work in overseeing risk management, the full Board regularly engages in discussions of the most significant risks that we are facing and how those risks are being managed, and the Board receives reports on risk management from our senior officers and from the chair of the Audit Committee. Mr. Venetucci’s extensive industry knowledge and successes uniquely qualify him to lead the company in assessing risks as CEO. The Board believes that the work undertaken by the Audit Committee, the full Board and the Chief Executive Officer, enables the Board to effectively oversee our risk management function.

Code of Business Conduct and Ethics

We have adopted a Code of Business Conduct and Ethics that applies to all our directors, officers (including our chief executive officer, chief financial officer and any person performing similar functions) and employees. We have made our Code of Business Conduct and Ethics available on our website at https://izea.com. Amendments to the Code of Business Conduct and Ethics or any grant of a waiver from a provision of the Code of Business Conduct and Ethics requiring disclosure under applicable SEC rules will also be disclosed on our website.

Anti-Hedging and Pledging Policies

    Under our Insider Trading Policy all directors and employees (including the named executive officers) are prohibited from pledging stock and engaging in any transactions (such as trading in options) that hedge or offset, or are designed to hedge or offset, any decrease in the market value of the Company’s securities.

17

Stockholder Recommendations for Board Candidates

    The Board will consider qualified candidates for director that are recommended and submitted by stockholders. Submissions that meet the current criteria for board membership are forwarded to the Nominations and Corporate Governance Committee for further review and consideration. The Nominations and Corporate Governance Committee will consider a recommendation only if appropriate biographical information and background material is provided on a timely basis, accompanied by a statement as to whether the stockholder or group of stockholders making the recommendation has beneficially owned more than five percent of our common stock for at least one year as of the date that the recommendation is made. To submit a recommendation for a nomination, a stockholder may write to the Board, at our principal executive office, Attention: Corporate Secretary.

In addition to satisfying the foregoing requirements, to comply with the universal proxy rules (once effective), shareholders who intend to solicit proxies in support of director nominees other than the company’s nominees must provide notice that sets forth the information required by Rule 14a-19 under the Exchange Act no later than August15, 2024.

    The Nominations and Corporate Governance Committee will evaluate any such candidates by following substantially the same process, and applying substantially the same criteria, as for candidates submitted by Board members, assuming that appropriate biographical and background material is provided for candidates recommended by stockholders and the process for submitting the recommendation is followed.

Stockholder Communications with the Board

Stockholders who wish to communicate directly with the Board or specified individual directors may do so by writing to:

Board of Directors (or name of individual director)

c/o Corporate Secretary

IZEA Worldwide, Inc.

1317 Edgewater Drive, #1880

Orlando, Florida 32804

We will forward all communications from security holders and interested parties to the full Board, to non-management directors, to an individual director or to the chairperson of the Board committee that is most closely related to the subject matter of the communication, except for the following types of communications: (i) communications that advocate that we engage in illegal activity; (ii) communications that, under community standards, contain offensive or abusive content; (iii) communications that have no relevance to our business or operations; and (iv) mass mailings, solicitations and advertisements. The Corporate Secretary will determine when a communication is not to be forwarded. Our acceptance and forwarding of communications to directors does not imply that directors owe or assume any fiduciary duties to persons submitting the communications.

Additionally, the Audit Committee has established procedures for the receipt, retention and confidential treatment of complaints received by IZEA regarding accounting, internal accounting controls or auditing matters, including procedures for confidential, anonymous submissions by employees with respect to such matters. Employees and stockholders may raise a question or concern to the Audit Committee regarding accounting, internal accounting controls or auditing matters by writing to:

Chairman, Audit Committee

c/o Corporate Secretary

IZEA Worldwide, Inc.

1317 Edgewater Drive, #1880

Orlando, Florida 32804

18

AUDIT COMMITTEE REPORT

The Audit Committee during 2023 was comprised of Patrick Venetucci (Chairman), John H. Caron, and Daniel R. Rua. In September 2024, Patrick Venetucci took over the position of Chief Executive Officer for the Company and Lindsay A. Gardner assumed the role of Audit Committee Chairman. None of these members serving on the Audit Committee is an officer or employee of the Company, and the Board has determined that each member of the Audit Committee meets the independence requirements promulgated by Nasdaq and the SEC, including Rule 10A-3(b)(1) under the Exchange Act.

The Audit Committee oversees the Company’s financial reporting process on behalf of the Board. Management is primarily responsible for the financial statements and the reporting process, including the systems of internal controls and the certification of the integrity and reliability of the Company’s internal controls procedures. The Audit Committee meets with IZEA’s independent registered public accounting firm, with and without management present, to discuss the results of their audits and reviews, their evaluations of IZEA’s internal controls and the overall quality of IZEA’s financial reporting. In fulfilling its oversight responsibilities, the Audit Committee has reviewed the Company’s audited financial statements included in the Annual Report on Form 10-K for the fiscal year ended December 31, 2023 and discussed them with both management and Grant Thornton (“GT”), IZEA’s independent registered public accounting firm. The Audit Committee also discussed with GT the matters required to be discussed by Auditing Standard No. 1301, “Communications with Audit Committees,” as adopted by the Public Company Accounting Oversight Board.

The Audit Committee has reviewed permitted services under the rules of the SEC as currently in effect and discussed with GT its independence from management and the Company, including the matters in the written disclosures and the letter from the independent registered public accounting firm required by the applicable requirements of the Public Company Accounting Oversight Board regarding GT’s communications with the Audit Committee concerning independence. When considering GT’s independence, the Audit Committee considered and discussed, among other matters, whether GT’s provision of non-audit services to IZEA is compatible with maintaining the independence of GT. Based on the Audit Committee’s review of the financial statements and the various discussions noted above, the Audit Committee concluded that it would be reasonable to recommend, and on that basis did recommend, to the Board that the audited consolidated financial statements be included in IZEA’s Annual Report on Form 10-K for the fiscal year ended December 31, 2023.

Respectfully submitted by the Audit Committee.

The Audit Committee:

Patrick J. Venetucci (Chairman - End 9/5/24)

Lindsay A. Gardner (Chairman - Begin 9/6/24)

John H. Caron

Daniel R. Rua

19

EXECUTIVE OFFICERS

The following table sets forth certain information concerning our executive officers:

Name	Age	Position
Patrick J. Venetucci	56	Chief Executive Officer
Peter J. Biere	68	Chief Financial Officer

You should refer to “Information Concerning Directors and Nominees for Director” above for biographical information about our Chief Executive Officer, Patrick J. Venetucci.

Peter J. Biere, Chief Financial Officer, joined us in April 2021 as a senior executive responsible for IZEA’s finance and accounting operation as well as guiding the Company’s broader fiscal strategy. Mr. Biere previously served as the Chief Financial Officer of BSQUARE (NASDAQ: BSQR), a technology provider of intelligent devices and software systems serving a global customer base with software and engineering services, from 2017 to 2019. Prior to BSQUARE, he served as Chief Financial Officer for Dreambox Learning from 2012 to 2016, a venture-backed EdTech SaaS provider. Earlier in his career, Mr. Biere served as the Chief Financial Officer of Lumera, a publicly-traded R&D stage nanotechnology developer of electro-optic modulators, from 2004 to 2009. He also served as Chief Financial Officer of Zones.com from 1993 to 1999, where he co-led the IPO and was part of the leadership team that grew revenue from $70 million to $500 million. Mr. Biere received a Bachelor of Science and a Master of Science degree in Accounting from the University of Iowa. He earned his CPA license in 1983 in the State of Texas (inactive).

EXECUTIVE AND DIRECTOR COMPENSATION

Summary Compensation Table

    The following table sets forth the cash compensation, as well as certain other compensation earned during the last two fiscal years, for (i) each person who served as our principal executive officer (“PEO”) during the year ended December 31, 2023; (ii) the two other most highly compensated executive officers other than the PEO who were serving as executive officers as of December 31, 2023; and (iii) up to two additional individuals for whom disclosure would have been provided pursuant to the foregoing clause (ii) but for the fact that such individuals were not serving as executive officers as of December 31, 2023 (collectively referred to as the “Named Executive Officers”):

Name and Principal Position	Year	Salary		Stock Awards (1)		Option Awards (1)		Non-Equity Incentive Plan Compensation (2)		All Other Compensation (3)		Total
Edward H. (Ted) Murphy (4)	2023	$	352,112	$	557,165	$	—	$	56,011	$	2,064	$	967,352
Former Chief Executive Officer, Founder	2022	$	316,461	$	305,493	$	—	$	92,147	$	814	$	714,915
	2021	$	310,278	$	394,000	$	361,646	$	90,894	$	814	$	1,157,632
Ryan S. Schram (5)	2023	$	337,573	$	137,185	$	—	$	242,053	$	1,260	$	718,071
Former President and Chief Operating Officer	2022	$	305,769	$	46,151	$	—	$	312,876	$	371	$	665,167
	2021	$	298,971	$	—	$	51,980	$	301,232	$	356	$	652,539
Peter J. Biere (6)	2023	$	317,308	$	157,125	$	—	$	55,081	$	—	$	529,514
Treasurer and Chief Financial Officer	2022	$	250,000	$	78,597	$	—	$	39,135	$	—	$	367,732
	2021	$	204,808	$	14,735	$	81,227	$	38,730	$	—	$	339,500

_______________

(1) Stock-based compensation is measured at the grant date, based on the award’s fair value, and is recognized as an expense over the employee’s requisite service period. We estimate the fair value of each stock option as of the date of grant using the Black-Scholes pricing model. Options typically vest ratably over four years, with one-fourth of options vesting one year from the date of grant and the remaining options vesting monthly, in equal increments over the remaining three-year period and generally having five or ten-year contract lives.

(2)     Bonus amounts paid in 2022 and 2023 consisted of incentive compensation payable pursuant to each individual’s employment agreement are reported in the “Non-Equity Incentive Plan Compensation” column of the Summary Compensation Table.

(3)     Represents insurance premiums paid by IZEA with respect to life insurance for the benefit of the Named Executive Officer.

(4)    For the year ended December 31, 2022, Mr. Murphy was awarded cash bonuses totaling $92,147 and restricted stock units valued at $305,493. No stock options were granted during this period in accordance with his quarterly and annual performance bonus awards under

20

his employment agreement. For the year ended December 31, 2023, Mr. Murphy was awarded cash bonuses totaling $56,011 and restricted stock units valued at $557,165 pursuant to quarterly and annual performance bonus awards granted in his employment agreement. Mr. Murphy’s employment ended on September 6, 2024.

(5)    For the year ended December 31, 2022, Mr. Schram was awarded cash bonuses totaling $312,876, restricted stock units valued at $46,151, and stock options with a fair value of $0 pursuant to quarterly and annual performance bonus awards granted in his employment agreement. For the year ended December 31, 2023, Mr. Schram was awarded cash bonuses totaling $242,053 and restricted stock units with a fair value of $137,185 pursuant to quarterly and annual performance bonus awards granted in his employment agreement. Mr. Schram’s employment ended on September 6, 2024.

(6)    For the year ended December 31, 2022, Mr. Biere was awarded cash bonuses totaling $39,135, restricted stock units valued at $78,597, and stock options with a fair value of $0 pursuant to quarterly and annual performance bonus awards granted in his employment agreement. For the year ended December 31, 2023, Mr. Biere was awarded cash bonuses totaling $55,081 and restricted stock units valued at $157,125 pursuant to quarterly and annual performance bonus awards granted in his employment agreement. See Employment Agreements below for details on Mr. Biere’s total compensation plan.

Employment Agreements

The following is a summary of the employment arrangements with our Named Executive Officers.

Edward H. (Ted) Murphy. On April 21, 2019, the Company entered into an amended and restated employment agreement with Mr. Murphy, with an initial term commencing April 21, 2019 and ending on April 20, 2022. Following the initial term, the employment agreement will automatically renew for successive one-year terms unless the Company or Mr. Murphy provides written notice of non-renewal at least 60 days prior to the end of the current term or the employment agreement is otherwise terminated pursuant to its terms. Pursuant to the employment agreement, Mr. Murphy receives an annual base salary of $249,900 with a guaranteed base salary increase of no less than 2% in April of each year and an automatic increase of 20% in the event that the Company reaches a market cap of $50 million for a specified amount of time. The employment agreement provides for annual stock options with a fair value of $200,000 vesting over four years in equal monthly installments, subject to a maximum of 200,000 underlying shares. In the event the fair market value of the stock option grant is less than $200,000 as limited by the 200,000-share maximum, Mr. Murphy is entitled to receive the difference in fair market value through a combination of cash and restricted stock units with the same vesting schedule as the stock options, at the sole discretion of the Board. Additionally, he is eligible for an annual bonus of no less than $85,000 in cash and up to $150,000 in stock options (subject to a 200,000-share maximum, with any resulting difference in value to be paid in a combination of cash and restricted stock units, at the sole discretion of the Board), in each case paid quarterly pursuant to the terms of the employment agreement. Such annual bonuses are based on the achievement of specified annual performance goals. Each such grant of stock options vests over three years in equal monthly installments.

Effective January 28, 2022, the Company entered into an amendment to Mr. Murphy’s employment agreement, that modifies the type of stock awards to be granted pursuant to Section 3 of his employment agreement. In lieu of stock options, the executive shall be granted restricted stock units (as defined in the Company’s 2011 Equity Incentive Plan).

On September 1, 2023, the Company entered into an amended and restated employment agreement with Mr. Murphy, with an initial term commencing September 1, 2023 and ending August 31, 2026. Following the initial term, the employment agreement will automatically renew for successive one-year terms unless the Company or Mr. Murphy provides written notice of non-renewal at least 60 days prior to the end of the current term or the employment agreement is otherwise terminated pursuant to its terms. Pursuant to the employment agreement, Mr. Murphy receives an annual base salary of $425,000. The employment agreement provides for an annual stock award with a fair value of $586,500 in the form of four (4) restricted stock unit awards which will each vest over three years following the grant date, one third upon 12 months of the grant date and quarterly thereafter. Additionally, he is eligible for a quarterly and annual bonus up to seventy-five percent (75%) of the Executive’s Base Salary in cash paid out in five (5) installments pursuant to the terms of the employment agreement. Such quarterly and annual bonuses are based on the achievement of specified annual performance goals.

Mr. Murphy's employment agreement is subject to early termination (i) by the Company or Mr. Murphy for any reason upon written notice, (ii) by the Company for cause (as such term is defined in the employment agreement), (iii) by Mr. Murphy for good reason (as such term is defined in the employment agreement), and (iv) in the case of death or disability. If terminated, for any reason other than death, disability or cause, Mr. Murphy will be entitled to a severance of twelve months of his current salary, a pro-rated portion of his Executive Bonus for the current fiscal year, and COBRA payments until the earliest of (i) the twelve-month anniversary of the Date of Termination; (ii) the Executive’s eligibility for group medical plan benefits under any other employer’s group medical plan or otherwise through other employment; or (iii) the cessation of the Executive’s continuation coverage rights under COBRA. In the case of termination due to disability, Mr. Murphy will be entitled to a severance of his current salary until such time (but no more than 120 days after such disability) that disability insurance plan payments commence. If there is a change of control (as defined in the employment agreement) and Mr. Murphy's employment terminates within three months prior to or twelve months following the change of control for reasons other than for cause, then

21

Mr. Murphy will be entitled to such amount equal to twelve months of his then-current base salary and COBRA payments until the earliest of (i) the twelve (12) month anniversary of the Date of Termination; (ii) the Executive’s eligibility for group medical plan benefits under any other employer’s group medical plan or otherwise through other employment; or (iii) the cessation of the Executive’s continuation coverage rights under COBRA. The employment agreement also provides for Mr. Murphy’s eligibility to receive benefits substantially similar to those of the Company’s other executives.

Effective September 6, 2024 the Company entered into a separation agreement with Mr. Murphy. The Company has agreed to pay Mr. Murphy a lump sum of $425,000, less applicable taxes and withholdings, upon separation. In the event the Company requires Mr. Murphy’s assistance beyond October 31, 2024, for transition-related matters, the Company will reimburse Mr. Murphy at a rate of $400 per hour for such cooperation. Additionally, Mr. Murphy will receive a pro-rated Q3 2024 bonus in accordance with the Company’s Short Term Incentive Plan, based on actual performance and payable at the same time as other executives receive their Q3 bonuses. Lastly, all outstanding equity compensation awards granted to Mr. Murphy shall immediately vest and become exercisable upon execution of the agreement.

Mr. Murphy may elect to continue health coverage under the Consolidated Omnibus Budget Reconciliation Act of 1985 (COBRA). If so, and upon Mr. Murphy’s copayment of the premium amounts at the active employees’ rate, the Company will make monthly payments equal to the employer contribution it would have provided had Mr. Murphy remained employed. This payment will continue until the earliest of the following: (i) the twelve-month anniversary of the Separation Date; (ii) Mr. Murphy’s eligibility for group medical plan benefits through another employer; or (iii) the cessation of COBRA continuation coverage rights. If necessary, the Company may convert these payments to payroll payments directly to Mr. Murphy, subject to tax-related deductions. Any additional COBRA premiums or costs incurred after the specified period will be the sole responsibility of Mr. Murphy.

    Ryan S. Schram. Effective January 1, 2021, the Company entered into an amended and restated employment agreement with Ryan S. Schram to serve as its President and Chief Operating Officer through January 4, 2024. The agreement auto-renews for successive one-year periods if no termination notice is provided. Per the agreement, Mr. Schram received an annual base salary of $300,000 with an annual increase of no less than 2% on January 1st of each year beginning in 2022. Additionally, on January 1st each year, Mr. Schram received annual stock options with a fair value of $25,000 vesting over four years in equal monthly installments. However, the number of underlying shares of common stock could not exceed 100,000 shares. In the event the fair market value of the stock option grant was less than $25,000 as limited by the share cap, Mr. Schram would be entitled to receive either 100% of the difference in fair market value in cash or 100% of the difference in fair market value in restricted stock with the same vesting schedule as the stock options, at the sole discretion of the Board. Mr. Schram would also be eligible for annual bonus distributions up to $100,000 in cash and $25,000 in stock options based on meeting certain key performance indicators (KPIs) set forth in his employment agreement, as well as an annual override cash bonus of 0.4% or 0.65% based on the Company’s gross revenue. The 100,000 share cap and payout rules also separately apply to the annual KPI-based stock award, except that Mr. Schram would be entitled to 50% of the difference in fair market value in cash. If Mr. Schram was terminated for any reason other than death, disability, or cause, or if he resigned for good reason (as those terms are defined in his employment agreement), Mr. Schram would be entitled to severance of six months’ current salary and bonus and override bonus as in effect on the date of termination. A change of control, under which Mr. Schram failed to retain his responsibilities, would be deemed to constitute good reason under his employment agreement.

Effective January 1, 2022, the Company entered into an amendment to Mr. Schram’s employment agreement that modifies the type of stock awards to be granted pursuant to Section 3 of his employment agreement. In lieu of stock options, the executive shall be granted restricted stock units (as defined in the Company’s 2011 Equity Incentive Plan).

On September 1, 2023, the Company entered into an amended and restated employment agreement with Mr. Schram, with an initial term commencing September 1, 2023 and ending August 31, 2026. Following the initial term, the employment agreement will automatically renew for successive one-year terms unless the Company or Mr. Schram provides written notice of non-renewal at least 60 days prior to the end of the current term or the employment agreement is otherwise terminated pursuant to its terms. Pursuant to the employment agreement, Mr. Schram receives an annual base salary of $400,000. The employment agreement provides for annual stock award with a fair value of $200,000 in the form of four (4) restricted stock units which will each vest over three years following the grant date, one third upon 12 months of the grant date and quarterly thereafter. Additionally, effective January 1, 2024, he is eligible for an executive bonus targeted at fifty percent (50%) Executive’s base salary in cash paid quarterly and annually pursuant to the terms of the employment agreement. Such quarterly and annual bonuses are based on the achievement of specified annual performance goals.

Mr. Schram's employment agreement is subject to early termination (i) by the Company or Mr. Schram for any reason upon written notice, (ii) by the Company for cause (as such term is defined in the employment agreement), (iii) by Mr. Schram for good reason (as such term is defined in the employment agreement), and (iv) in the case of death or disability. If terminated, for any reason other than death, disability or cause, Mr. Schram will be entitled to a severance of twelve months of his current salary, a pro-rated portion of his Executive Bonus for the current fiscal year, and COBRA payments until the earliest of (i) the twelve-month anniversary of the Date of Termination; (ii) the Executive’s eligibility for group medical plan benefits under any

22

other employer’s group medical plan or otherwise through other employment; or (iii) the cessation of the Executive’s continuation coverage rights under COBRA. In the case of termination due to disability, Mr. Schram will be entitled to a severance of his current salary until such time (but no more than 120 days after such disability) that disability insurance plan payments commence. If there is a change of control (as defined in the employment agreement) and Mr. Schram's employment terminates within three months prior to or twelve months following the change of control for reasons other than for cause, then Mr. Schram will be entitled to such amount equal to twelve months of his then-current base salary and COBRA payments until the earliest of (i) the twelve (12) month anniversary of the Date of Termination; (ii) the Executive’s eligibility for group medical plan benefits under any other employer’s group medical plan or otherwise through other employment; or (iii) the cessation of the Executive’s continuation coverage rights under COBRA. The employment agreement also provides for Mr. Schram’s eligibility to receive benefits substantially similar to those of the Company’s other executives.

Effective September 6, 2024 the Company entered into a separation agreement with Mr. Schram. The Company has agreed to pay Mr. Schram a lump sum of $400,000, less applicable taxes and withholdings, upon separation. In the event the Company requires Mr. Schram’s assistance beyond October 31, 2024, for transition-related matters, the Company will reimburse Mr. Schram at a rate of $400 per hour for such cooperation. Additionally, Mr. Schram will receive a pro-rated Q3 2024 bonus in accordance with the Company’s Short Term Incentive Plan, based on actual performance and payable at the same time as other executives receive their Q3 bonuses. Lastly, all outstanding equity compensation awards granted to Mr. Schram shall immediately vest and become exercisable upon execution of the agreement.

Mr. Schram may elect to continue health coverage under the Consolidated Omnibus Budget Reconciliation Act of 1985 (COBRA). If so, and upon Mr. Schram’s copayment of the premium amounts at the active employees’ rate, the Company will make monthly payments equal to the employer contribution it would have provided had Mr. Schram remained employed. This payment will continue until the earliest of the following: (i) the twelve-month anniversary of the Separation Date; (ii) Mr. Schram’s eligibility for group medical plan benefits through another employer; or (iii) the cessation of COBRA continuation coverage rights. If necessary, the Company may convert these payments to payroll payments directly to Mr. Schram, subject to tax-related deductions. Any additional COBRA premiums or costs incurred after the specified period will be the sole responsibility of Mr. Schram.

On September 6, 2024, the Company entered into an employment agreement with Patrick J. Venetucci to serve as its Chief Executive Officer through December 31, 2027. Pursuant to the employment agreement, Mr. Venetucci receives an annual base salary of $450,000. The employment agreement Mr. Venetucci is eligible to receive 75% of his salary based on the achievement of certain key performance indicators set at the beginning of each year. The target Executive Bonus for fiscal year 2024 shall be prorated for the months of employment in the fiscal year. The employment agreement provides for a long-term incentive stock award of 980,800 restricted stock units. The first grant of 490,400 of the RSUs shall vest in 16 equal quarterly amounts starting on October 31, 2024 and every three months thereafter until fully vested (collectively, the “Time-Based RSUs”). The second grant of 490,400 of the RSUs will vest based on the annual common share price performance (“SPP”) defined as the growth in share price from $2.00 to $10.00 per share (collectively, the “Performance-Based RSUs”). For purposes of the Performance-Based RSUs, the SPP shall be measured by the ratio of (i) the volume weighted average price (“VWAP”) for the fourth quarters of each of 2024, 2025, 2026, and 2027 period minus $2.00, divided by (ii) $8.00; minus any previously vested SPP shares. Vesting is cumulative, with no recoupment for years with a negative ratio, and any Time-Based RSUs that remain unvested after the Q4 2027 calculation shall be forfeited. The formula used to calculate the SPP and Time-Based RSUs are subject to any stock split effected by the Company.

Following the initial term, the Employment Agreement will automatically renew for successive one-year terms unless the Company or Mr. Venetucci provides written notice of non-renewal at least 60 days prior to the end of the current term. The Employment Agreement is subject to early termination (i) by the Company or Mr. Venetucci for any reason upon written notice, (ii) by the Company for cause (as such term is defined in the Employment Agreement), (iii) by Mr. Biere for good reason (as such term is defined in the Employment Agreement), and (iv) in the case of Mr. Venetucci’s death or disability. If the Employment Agreement is terminated for any reason other than by the Company for cause or by Mr. Venetucci without good reason, Mr. Venetucci will be entitled to payment of expenses, accrued and unused vacation time, and severance of twelve months of his then-current salary. In the case of termination due to disability, Mr. Venetucci will be entitled to severance of his then-current salary until such time (but no more than 120 days after such disability) that disability insurance plan payments commence. If there is a change of control (as defined in the Employment Agreement) and Mr. Biere’s employment terminates within six months following the change of control for reasons other than for cause or without good reason, then Mr. Biere will be entitled to severance of six months of his then-current salary and six months of his COBRA payments. Additionally, upon a change of control (as such term is defined in the Employment Agreement), Mr. Venetucci’s unvested equity awards will be subject to acceleration pursuant to the terms of the Employment Agreement.

Peter J. Biere. On April 1, 2021, the Company entered into an employment agreement with Peter J. Biere to serve as its Chief Financial Officer through March 31, 2022. Pursuant to the employment agreement, Mr. Biere receives an annual base salary of $250,000 and received a relocation reimbursement of up to $25,000. The employment agreement provides for a one-

23

time issuance of 20,000 stock options and an annual issuance of stock options valued at $25,000, with 25% vesting one year from issuance and the remaining 75% vesting in equal monthly installments thereafter over three years. Additionally, Mr. Biere is eligible to receive bonuses up to $120,000 annually (or higher as determined by the Board), to be paid in a combination of cash, stock options, and restricted stock units on a quarterly basis, based on the achievement of certain key performance indicators set at the beginning of each year. Each grant of bonus stock options or restricted stock units shall vest over three years in equal monthly installments.

Following the initial term, the Employment Agreement will automatically renew for successive one-year terms unless the Company or Mr. Biere provides written notice of non-renewal at least 60 days prior to the end of the current term. The Employment Agreement is subject to early termination (i) by the Company or Mr. Biere for any reason upon written notice, (ii) by the Company for cause (as such term is defined in the Employment Agreement), (iii) by Mr. Biere for good reason (as such term is defined in the Employment Agreement), and (iv) in the case of Mr. Biere’s death or disability. If the Employment Agreement is terminated for any reason other than by the Company for cause or by Mr. Biere without good reason, Mr. Biere will be entitled to payment of expenses, accrued and unused vacation time, and severance of six months of his then-current salary. In the case of termination due to disability, Mr. Biere will be entitled to severance of his then-current salary until such time (but no more than 120 days after such disability) that disability insurance plan payments commence. If there is a change of control (as defined in the Employment Agreement) and Mr. Biere’s employment terminates within six months following the change of control for reasons other than for cause or without good reason, then Mr. Biere will be entitled to severance of six months of his then-current salary and six months of his COBRA payments. Additionally, upon a change of control (as such term is defined in the Employment Agreement), Mr. Biere’s unvested equity awards will be subject to acceleration pursuant to the terms of the Employment Agreement.

Effective January 1, 2022, the Company entered into an amendment to Mr. Biere’s employment agreement that modifies the type of stock awards to be granted pursuant to Section 3 of his employment agreement. In lieu of stock options, the executive shall be granted restricted stock units (as defined in the Amended and Restated 2011 Equity Incentive Plan).

On September 1, 2023, the Company entered into an amended and restated employment agreement with Mr. Biere, with an initial term commencing September 1, 2023 and ending on August 31, 2026. Following the initial term, the employment agreement will automatically renew for successive one-year terms unless the Company or Mr. Biere provides written notice of non-renewal at least 60 days prior to the end of the current term or the employment agreement is otherwise terminated pursuant to its terms. Pursuant to the employment agreement, Mr. Biere receives an annual base salary of $320,000. The employment agreement provides for annual stock award with a fair value of $236,800 in the form of four (4) restricted stock units which will each vest over three years following the grant date, one third upon 12 months of the grant date and quarterly thereafter. Additionally, he is eligible for an annual bonus up to sixty percent (60%) of the Executive’s Base Salary in cash paid out in five (5) installments pursuant to the terms of the employment agreement. Such annual bonuses are based on the achievement of specified annual performance goals.

Mr. Biere’s employment agreement is subject to early termination (i) by the Company or Mr. Biere for any reason upon written notice, (ii) by the Company for cause (as such term is defined in the employment agreement), (iii) by Mr. Biere for good reason (as such term is defined in the employment agreement), and (iv) in the case of death or disability. If terminated, for any reason other than death, disability or cause, Mr. Biere will be entitled to a severance of nine months of his current salary, a pro-rated portion of his Executive Bonus for the current fiscal year, and COBRA payments until the earliest of (i) the nine-month anniversary of the Date of Termination; (ii) the Executive’s eligibility for group medical plan benefits under any other employer’s group medical plan or otherwise through other employment; or (iii) the cessation of the Executive’s continuation coverage rights under COBRA. In the case of termination due to disability, Mr. Biere will be entitled to a severance of his current salary until such time (but no more than 120 days after such disability) that disability insurance plan payments commence. If there is a change of control (as defined in the employment agreement) and Mr. Biere’s employment terminates within three months prior to or twelve months following the change of control for reasons other than for cause, then Mr. Biere will be entitled to such amount equal to nine months of his then-current base salary and COBRA payments until the earliest of (i) the nine (9) month anniversary of the Date of Termination; (ii) the Executive’s eligibility for group medical plan benefits under any other employer’s group medical plan or otherwise through other employment; or (iii) the cessation of the Executive’s continuation coverage rights under COBRA. The employment agreement also provides for Mr. Biere’s eligibility to receive benefits substantially similar to those of the Company’s other executives.

24

Outstanding Equity Awards at Fiscal Year End

    Listed below is information with respect to unexercised options and equity incentive awards held by each Named Executive Officer as of December 31, 2023 pursuant to our equity incentive plans:

	Option Awards
Name	Number of Securities Underlying Unexercised Options: Exercisable	Number of Securities Underlying Unexercised Options: Unexercisable		Option Exercise Price (1)		Option Expiration Date
Edward H. (Ted) Murphy	10,000	—		$	20.80	12/26/2024
President and Chief Executive Officer	1,825	—		$	31.20	4/1/2025
	777	—		$	33.60	7/1/2025
	827	—		$	32.00	10/1/2025
	9,347	—		$	31.36	11/30/2025
	2,075	—		$	27.64	3/30/2026
	1,385	—		$	23.00	5/16/2026
	2,015	—		$	28.88	8/16/2026
	1,575	—		$	18.88	11/17/2026
	10,000	—		$	19.00	11/30/2026
	3,563	—		$	16.80	3/31/2027
	2,972	—		$	11.00	5/12/2027
	7,029	—		$	7.80	8/14/2027
	10,000	—		$	18.60	11/30/2027
	1,905	—		$	5.36	6/5/2028
	3,445	—		$	4.40	8/16/2028
	2,151	—		$	5.84	11/16/2028
	10,000	—		$	5.32	11/30/2028
	50,000	—		$	4.24	4/23/2029
	2,348	—		$	2.60	5/14/2029
	3,385	—		$	1.68	8/14/2029
	50,000	—		$	1.24	8/27/2029
	5,729	—		$	0.69	4/1/2030
	40,906	5,844	(3)	$	5.04	8/27/2030
	4,706	277	(3)	$	15.40	4/1/2031
	3,038	276	(3)	$	11.84	5/18/2031
	4,306	861	(2)	$	7.56	8/17/2031
	15,849	9,522	(3)	$	9.12	8/27/2031
	2,485	828	(3)	$	9.64	11/16/2031
Ryan S. Schram	1,667	—		$	22.40	1/2/2025
Chief Operating Officer	305	—		$	31.20	4/1/2025
	128	—		$	33.60	7/1/2025
	140	—		$	32.00	10/1/2025
	1,589	—		$	30.40	1/1/2026
	346	—		$	27.64	3/30/2026
	231	—		$	23.00	5/16/2026
	336	—		$	28.88	8/16/2026
	263	—		$	18.88	11/17/2026

25

	1,667	—		$	18.04	1/1/2027
	594	—		$	16.80	3/31/2027
	603	—		$	11.00	5/12/2027
	1,064	—		$	7.80	8/14/2027
	1,667	—		$	18.08	1/1/2028
	701	—		$	5.36	6/5/2028
	811	—		$	4.40	8/16/2028
	156	—		$	5.84	11/16/2028
	1,667	—		$	3.92	1/1/2029
	1,628	—		$	2.60	5/14/2029
	2,393	—		$	1.68	8/14/2029
	1,667	—		$	0.95	1/1/2030
	1,597	70		$	0.69	3/31/2030
	3,107	932	(3)	$	7.28	1/1/2031
	582	252	(3)	$	15.40	4/1/2031
	553	—		$	11.84	5/18/2031
	861	—		$	7.56	8/17/2031
	552	—		$	9.64	11/16/2031
Peter J. Biere	3,542	1,458	(3)	$	15.40	4/1/2031
Chief Financial Officer and Treasurer	1033	207	(2)	$	7.56	8/17/2031
	596	199	(2)	$	9.64	11/16/2031

(1)Unless otherwise indicated, the option exercise price represents the closing price of the Company’s common stock on the date of grant or the closing price of its common stock on the last trading day prior to the grant date if the grant date falls on a non-trading day. Each of these grants has a ten-year term, indicating that the grant date was 10 years prior to the indicated Option Expiration Date.

(2)Represents the unvested portion of annual or quarterly bonus awards granted in accordance with the officer’s employment agreement based on achievement of certain key performance indicators set at the beginning of each year, vesting in equal monthly installments over four years subsequent to the grant date.

(3)Represents the unvested portion of annual stock options granted pursuant to an employment agreement and vesting in equal monthly installments over four years subsequent to the grant date.

Listed below is information with respect to unvested shares of restricted stock or restricted stock units held by each Named Executive Officer as of December 31, 2023 pursuant to our equity incentive plans:

		Stock Awards
Name		Equity Incentive Plan Awards: Number of Unearned Shares, Units or Other Rights That Have Not Vested	Equity Incentive Plan Awards: Market Value or Payout Value of Unearned Shares, Units or Other Rights That Have Not Vested
Edward H. (Ted) Murphy	(1)	4,111	$	8,263
President and Chief Executive Officer	(1)	1,632	$	3,280
	(1)	3,748	$	7,533
	(1)	32,286	$	64,895
	(1)	4,377	$	8,798
	(2)	8,782	$	17,652
	(2)	3,912	$	7,863
	(2)	8,591	$	17,268
	(2)	76,567	$	153,900
	(2)	66,648	$	133,962
	(2)	67,882	$	136,443

26

Ryan S. Schram	(3)	489	$	983
Chief Operating Officer	(3)	72	$	145
	(3)	105	$	211
	(3)	240	$	482
	(4)	2,337	$	4,697
	(5)	8,640	$	17,366
	(6)	489	$	983
	(6)	280	$	563
	(6)	970	$	1,950
	(6)	22,727	$	45,681
	(6)	23,148	$	46,527
	(6)	519	$	1,043
Peter J. Biere	(7)	267	$	537
Chief Financial Officer	(7)	227	$	456
	(8)	2,211	$	4,444
	(9)	1,505	$	3,025
	(9)	921	$	1,851
	(9)	1,886	$	3,791
	(9)	2,191	$	4,404
	(10)	9,602	$	19,300
	(11)	4,213	$	8,468
	(11)	26,909	$	54,087
	(11)	27,407	$	55,088

(1)On April 1, 2022, May 19, 2022, August 16, 2022, and November 18, 2022, we issued 9,851, 3,666, 6,740, and 6,847 restricted stock units for Mr. Murphy’s quarterly stock bonus awards under his employment agreement. The stock was initially valued at $65,017, $15,695, $27,230, and $18,213. On August 27, 2022, the Company issued 50,000 restricted stock units for Mr. Murphy’s 2022 annual stock award under his employment agreement. The stock was initially valued at $179,500 and vests monthly over 48 months after issuance.

(2)On May 26, 2023, August 18, 2023, September 1, 2023, and October 31, 2023, we issued 5,024, 9,978, 66,648, and 67,882 restricted stock units for Mr. Murphy’s 2023 quarterly stock bonus awards under his employment agreement. The stock was initially valued at $14,668, $20,654, $146,626, and $146,625. On April 14, 2023 the Company issued 11,707 restricted stock units initially valued at $28,592 for Mr. Murphy’s KPI Stock Bonus. On August 27, 2023 the Company issued 85,470 restricted stock units for Mr. Murphy’s 2023 annual stock award. The stock was initially valued at $200,000 and vests quarterly over 36 months after issuance. As of December 31, 2023, 278,536 restricted stock units are unvested with a total market value of $559,857 based on the closing stock price of $2.01.

(3)On April 3, 2020, May 31, 2020, August 31, 2020 and November 30, 2020, we issued 7,818, 837, 683 and 1,119 restricted stock units, respectively, for Mr. Schram’s 2020 quarterly stock bonus awards under his employment agreement. The stock was initially valued at $4,838, $2,041, $3,085, and $4,088 and vests in equal monthly installments over 48 months after issuance.

(4)On January 1, 2022, we issued 4,664 restricted stock units for Mr. Schram’s 2021 annual stock bonus award under his employment agreement. The stock was initially valued at $25,000 and vests in equal monthly installments over 48 months after issuance.

(5)On January 1, 2023, we issued 11,511 restricted stock units for Mr. Schram’s 2022 annual stock bonus award under his employment agreement. The stock was initially valued at $25,000 and vests in equal monthly installments over 48 months after issuance.

(6)On May 26, 2023, August 18, 2023, September 1, 2023, and October 31, 2023, we issued 838, 1,663, 22,727, and 23,148 restricted stock units for Mr. Schram’s 2023 quarterly stock bonus awards under his employment agreement. The stock was initially valued at $2,445, $3,442, $49,999, and $50,000. On April 14, 2023 and on November 24, 2023, the Company issued 1,952 and 623 restricted stock units initially valued at $4,766 and $1,533 for Mr. Schram’s KPI Stock Bonus. As of December 31, 2023, 60,016 restricted stock units are unvested with a total market value of $120,631 based on the closing stock price of $2.01.

(7)All restricted stock units convert to an equal number of common stock shares upon vesting. On August 17, 2021 and November 16, 2021, the Company issued 1,072 and 688 restricted stock units for Mr. Biere’s quarterly 2021 stock bonus awards under his

27

employment agreement. The stock was initially valued at $8,101 and $6,635 and vests in equal monthly installments over 36 months after issuance.

(8)On April 1, 2022, the Company issued 3,788 restricted stock units for Mr. Biere’s annual stock award under his employment agreement. The stock was initially valued at $25,000 and has cliff vesting of 25% at one year and then quarterly over 36 months.

(9)On April 1, 2022, May 19, 2022, August 16, 2022, and November 18, 2022, the Company issued 3,619, 1,845, 3,236, and 3,287 restricted stock units for Mr. Biere’s 2022 quarterly stock award under his employment agreement. The stock was initially valued at $23,885, $7,894, $13,071, and $8,745 and vest quarterly over 36 months.

(10)On April 1, 2023, the Company issued 9,602 restricted stock units for Mr. Biere’s annual stock award under his employment agreement. The stock was initially valued at $25,000 and has cliff vesting of 25% at one year and then quarterly over 36 months.

(11)On April 14, 2023, September 1, 2023, and October 31, 2023, we issued 5,620, 26,909, and 27,407 restricted stock units for Mr. Biere’s 2023 quarterly stock awards under his employment agreement. The stock was initially valued at $13,726, $59,200 and $59,199. As of December 31, 2023, 77,339 restricted stock units are unvested with a total market value of $155,451 based on the closing stock price of $2.01.

Equity Incentive Plans

    In May 2011, the Board adopted the 2011 Equity Incentive Plan of IZEA, Inc., which was amended and restated in 2020 (the “May 2011 Plan”). The May 2011 Plan allows us to award restricted stock, restricted stock units and stock options, covering up to 1,875,000 shares of common stock as incentive compensation for our employees and consultants. On August 22, 2011, the Board adopted the 2011 B Equity Incentive Plan (the “August 2011 Plan”) reserving 1,094 shares of common stock for issuance under the August 2011 Plan. As of December 31, 2023, an aggregate of 616,037 shares of common stock have been issued in respect of exercised and vested awards under the May 2011 Plan and the August 2011 Plan. The August 2011 Plan expired in 2021 and no new grants may be made thereunder. All shares have been adjusted for the reverse stock split dated June 16, 2023.

    Under both the May 2011 Plan and the August 2011 Plan, the Board determines the exercise price to be paid for the option shares, the period within which each award may be exercised, and the terms and conditions of each award, including any future vesting restrictions. The exercise price of incentive and non-qualified stock options may not be less than 100% of the fair market value per share of our common stock on the grant date. If an individual owns stock representing more than 10% of the outstanding shares, the price of each share of an incentive stock option must be equal to or exceed 110% of fair market value. Unless otherwise determined by the Board at the time of grant, the purchase price is set at the fair market value of our common stock on the grant date (or the last trading day prior to the grant date, if it is awarded on a non-trading day). Additionally, the term is set at ten years and the option typically vests on a straight-line basis over the requisite service period as follows: 25% one year from the date of grant with the remaining vesting monthly, in equal increments over the following three years. We issue new shares for any stock awards or options exercised under our 2011 Equity Incentive Plans.

    Our 2014 Employee Stock Purchase Plan (the “ESPP”) provides for the issuance of up to 125,000 shares of our common stock, adjusted for the reverse stock split dated June 16, 2023. Any employee regularly employed by us for 90 days or more on a full-time or part-time basis (20 hours or more per week on a regular schedule) is eligible to participate in the ESPP. The ESPP operates in successive six-month offering periods commencing at the beginning of each fiscal year half. Each eligible employee who has elected to participate may purchase up to 10% of their annual compensation in common stock not to exceed $21,250 annually or 2,000 shares per offering period. The purchase price will be the lower of (i) 85% of the fair market value of a share of common stock on the first day of the offering period or (ii) 85% of the fair market value of a share of common stock on the last day of the offering period. The ESPP will continue until January 1, 2024, unless otherwise terminated by our Board. As of December 31, 2023, 44,022 shares have been issued under the ESPP.

On November 30, 2023, the IZEA Board of Directors adopted the IZEA Worldwide, Inc. 2023 Inducement Plan (the “Inducement Plan”) to accommodate equity grants to new employees hired by IZEA or its subsidiaries, including employment inducements in connection with acquisition transactions. Under the Inducement Plan, IZEA may grant restricted stock units (“RSUs”), including performance-based and time-based RSUs, with respect to up to a total of 1,800,000 shares of IZEA common stock. As permitted by Rule 5635(c)(4) of the Nasdaq Listing Rules, the Inducement Plan was adopted without stockholder approval. As of October 15, 2024, an aggregate of 287,145 RSUs have been issued under the Inducement Plan.

28

The following table sets forth information regarding the securities authorized for issuance under our equity compensation plans as of December 31, 2023:

Plan Category	Number of securities to be issued upon exercise of outstanding options, warrants and rights	Weighted-average exercise price of outstanding options, warrants and rights		Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column (a))
	(a)	(b)		(c) (1)
Equity compensation plans approved by security holders	1,644,773	$	9.53	3,057,544

(1) As of December 31, 2023, we had 3,057,544 shares of common stock available for future issuance under our May 2011 Equity Incentive Plan. The 3,057,544 is made up of 1,595,898 restricted stock awards and 1,461,646 inducement stock awards.

As of October 15, 2024, we had 16,922,268 shares of common stock issued, which includes 0 shares of unvested restricted stock, outstanding stock options to purchase 336,561 shares of our common stock at an average exercise price of $10.65 per share and unvested restricted stock units of 1,503,435 shares with an intrinsic value of $4,172,165.

Pay Versus Performance

For the purposes of this section, we have elected to take advantage of certain of the scaled disclosure available to the Company for smaller reporting companies. As required by Section 953(a) of the Dodd-Frank Wall Street Reform and Consumer Protection Act, and Item 402(v) of Regulation S-K, we are providing the following information about the relationship between executive compensation actually paid to certain individuals by the Company and certain financial performance of the Company. For further information concerning the Company’s pay-for-performance philosophy and how the Company aligns executive compensation with the Company’s performance, refer to the Executive Compensation section of this proxy statement.

Fiscal Year	Summary Compensation Table Total for PEO1		Compensation Actually Paid to PEO2		Average Summary Compensation Table Total for Non-PEO NEOs3		Average Compensation Actually Paid to Non-PEO NEOs4		Value of Initial Fixed $100 Investment Based On Company Total Shareholder Return5		Net Income6
2023	$	967,352	$	924,891	$	623,793	$	646,314	$	63	$	(7,349,360)
2022	714,915		497,718		515,729		460,821		39		(4,469,498)
2021	1,157,632		1,106,384		496,020		642,223		75		(3,140,621)

29

1	This column represents the amount of total compensation reported for Edward H. Murphy (our Chairman, President, and Chief Executive Officer) for each corresponding fiscal year in the “Total” column of the Summary Compensation Table. Please refer to the Summary Compensation Table in this proxy statement.
2	This column represents the amount of “compensation actually paid” to Mr. Murphy, as computed in accordance with Item 402(v) of Regulation S-K. The amounts do not reflect the actual amount of compensation earned by or paid to Mr. Murphy during the applicable fiscal year. In accordance with the requirements of Item 402(v) of Regulation S-K, the following adjustments were made to Mr. Murphy’s total compensation for fiscal year 2023 to determine the “compensation actually paid” to Mr. Murphy for fiscal year 2023:
3	This column represents the average of the amounts reported for the Company’s named executive officers as determined in accordance with Item 402(m)(2) of Regulation S-K as a group (excluding Mr. Murphy) (NEOs), as reported in the “Total” column of the Summary Compensation Table in each applicable fiscal year. Please refer to the Summary Compensation Table in the Company’s proxy statement for the applicable fiscal year. The names of each of the NEOs (excluding Mr. Murphy) included for purposes of calculating the average amounts in each applicable fiscal year are as follows: (i) for 2023, Messrs. Schram and Biere; (ii) for 2022, Messrs. Schram and Biere; and (iii) for 2021, Messrs. Schram and Biere:
4	This column represents the average amount of “compensation actually paid” to the NEOs as a group (excluding Mr. Murphy), as computed in accordance with Item 402(v) of Regulation S-K. The dollar amounts do not reflect the actual average amount of compensation earned by or paid to the NEOs as a group (excluding Mr. Murphy) during the applicable fiscal year. In accordance with the requirements of Item 402(v) of Regulation S-K, the following adjustments were made to average total compensation for the NEOs as a group (excluding Mr. Murphy) for fiscal year 2023 to determine the compensation actually paid to the NEOs as a group in fiscal year 2023, using the same adjustment methodology described above in Note 2(c):
5	This column represents cumulative Company TSR. Company TSR is calculated by dividing the sum of the cumulative amount of dividends for each measurement period (2023, 2022-2023, and 2021-2023), assuming dividend reinvestment, and the difference between the Company’s share price at the end and the beginning of the measurement period by the Company’s share price at the beginning of the measurement period.
6	This column represents the amount of net income reflected in the Company’s audited financial statements for the applicable fiscal year.

Fiscal Year	Reported Summary Compensation Table Total for PEO(a)		Reported Summary Compensation Table Value of PEO Equity Awards(b)		Adjusted Value of Equity Awards(c)		Compensation Actually Paid to PEO
2023	$	967,352	$	557,165	$	514,704	$	924,891

(a)	This column represents the amount of total compensation reported for Mr. Murphy for each corresponding fiscal year in the “Total” column of the Summary Compensation Table. Please refer to the Summary Compensation Table in this proxy statement.
(b)	This column represents the aggregate grant date fair value of equity awards reported in the “Stock Awards” and “Option Awards” columns in the Summary Compensation Table for the applicable fiscal year. Please refer to the Summary Compensation Table in this proxy statement. The amount in this column for each fiscal year is replaced with the corresponding amount reported under the Adjusted Value of Equity Awards column in order to arrive at compensation actually paid to the NEOs as a group for the applicable fiscal year.
(c)	This column includes an adjustment to the amounts in the “Stock Awards” and “Option Awards” columns in the Summary Compensation Table for the applicable fiscal year (a “Subject Year”). For a Subject Year, the adjusted value replaces the “Stock Awards” and “Option Awards” columns in the Summary Compensation Table for Mr. Murphy to arrive at “compensation actually paid” to Mr. Murphy for that Subject Year. The adjusted amount is determined by adding (or subtracting, as applicable) the following for that Subject Year: (i) the fiscal year-end fair value of any equity awards granted in the Subject Year that are outstanding and unvested as of the end of the Subject Year; (ii) the amount of change as of the end of the Subject Year (from the end of the prior fiscal year) in the fair value of any awards granted in prior fiscal years that are outstanding and unvested as of the end of the Subject Year; (iii) for awards that are granted and vest in the Subject Year, the fair value as of the vesting date; (iv) for awards granted in prior fiscal years that vest in the Subject Year, the amount equal to the change as of the vesting date (from the end of the prior fiscal year) in the fair value; (v) for awards granted in prior fiscal years that are determined to fail to meet the applicable vesting conditions during the Subject Year, a deduction for the amount equal to the fair value at the end of the prior fiscal year; and (vi) the dollar value of any dividends or other earnings paid on stock or option awards in the Subject Year prior to the vesting date that are not otherwise reflected in the fair value of such award or included in any other component of total compensation for the Subject Year. The amounts added or subtracted to determine the adjusted average amount are as follows:

30

Fiscal Year	Fiscal Year End Fair Value of Equity Awards Granted in the Fiscal Year	Fiscal Year over Fiscal Year Change in Fair Value of Outstanding and Unvested Equity Awards at Fiscal Year End Granted in Prior Fiscal Years	Fair Value as of Vesting Date of Equity Awards Granted and Vested in the Fiscal Year	Change in Fair Value of Equity Awards Granted in Prior Fiscal Years that Vested in the Fiscal Year	Fair Value at the End of the Prior Fiscal Year of Equity Awards that Failed to Meet Vesting Conditions in the Fiscal Year	Value of Dividends or other Earnings Paid on Stock or Option Awards not Otherwise Reflected in Fair Value or Total Compensation in the Summary Compensation Table for the Fiscal Year	Adjusted Value of Equity Awards
2023	$467,088	$4,112	$32,170	$11,334	$—	$—	$514,704
2022	146,180	(87,967)	28,432	1,651	—	—	88,296

The fair value or change in fair value, as applicable, of stock awards and option awards was determined by reference to, (1) for restricted stock, the closing price of our common stock on the applicable measurement date, (2) for performance-based restricted stock units (excluding market-conditioned (relative total shareholder return (TSR) based) performance-based restricted stock units), the closing price of our common stock on the applicable measurement date multiplied by the probability of achievement as of such date, (3) for market-conditioned performance-based restricted stock units, a Monte Carlo simulation as of the applicable measurement date and (4) for stock options, the fair value or change in fair value, as applicable, was determined by utilizing the Black-Scholes valuation model. The model references the closing stock price, in addition to the stock option’s strike price, expected life, volatility, expected dividend yield, and risk-free rate as of the measurement date.

Fiscal Year	Average Reported Summary Compensation Table Total for Non-PEO NEOs (a)		Average Reported Summary Compensation Table Value of Non-PEO NEO Equity Awards(b)		Average Non-PEO NEO Adjusted Value of Equity Awards(c)		Average Compensation Actually Paid to Non-PEO NEOs
2023	$	623,793	$	147,155	$	169,676	$	646,314
2022	515,729		62,374		7,466		460,821
2021	496,020		73,971		220,174		642,223

(a)	This column represents the average of the amounts reported for the Company’s NEOs as a group (excluding Mr. Murphy) in the “Total” column of the Summary Compensation Table in each applicable fiscal year. Please refer to the Summary Compensation Table in this proxy statement for the applicable fiscal year.
(b)	This column represents the average of the total amounts reported for the NEOs as a group (excluding Mr. Murphy) in the “Stock Awards” and “Option Awards” columns in the Summary Compensation Table in each applicable fiscal year. Please refer to the Summary Compensation Table in this proxy statement for the applicable fiscal year. The amount in this column for each fiscal year is replaced with the corresponding amount reported under the Average Non-PEO NEO Adjusted Value of Equity Awards column in order to arrive at compensation actually paid for the applicable fiscal year.
(c)	This column includes an adjustment to the average of the amounts reported for the NEOs as a group (excluding Mr. Murphy) in the “Stock Awards” and “Option Awards” columns in the Summary Compensation Table in each applicable fiscal year determined using the same methodology described above in Note 2(c). For each fiscal year, the adjusted value replaces the “Stock Awards” and “Option Awards” columns in the Summary Compensation Table for each NEO (excluding Mr. Murphy) to arrive at “compensation actually paid” to each NEO (excluding Mr. Murphy) for that fiscal year, which is then averaged to determine the average “compensation actually paid” to the NEOs (excluding Mr. Murphy) for that fiscal year. The amounts added or subtracted to determine the adjusted average amount are as follows:

31

Fiscal Year	Average Fiscal Year End Fair Value of Equity Awards Granted in the Fiscal Year	Average Fiscal Year over Fiscal Year Change in Fair Value of Outstanding and Unvested Equity Awards at Fiscal Year End Granted in Prior Fiscal Years	Average Fair Value as of Vesting Date of Equity Awards Granted in the Fiscal Year and Vested in the Fiscal Year	Average Change in Fair Value of Equity Awards Granted in Prior Fiscal Years that Vested in the Fiscal Year	Average Fair Value at the End of the Prior Fiscal Year of Equity Awards that Failed to Meet Vesting Conditions in the Fiscal Year	Average Value of Dividends or other Earnings Paid on Stock or Option Awards not Otherwise Reflected in Fair Value or Total Compensation in the Summary Compensation Table for the Fiscal Year	Adjusted Average Value of Equity Awards
2023	$125,529	$35,320	$8,302	$525	$—	$—	$169,676
2022	21,742	(23,030)	7,865	889	—	—	7,466

The fair value or change in fair value, as applicable, of stock awards and stock options was determined using the same methodology described above in Note 2(c).

Description of the Information Presented in the Pay versus Performance Table

As described in greater detail in the Executive Compensation section of this proxy statement, the Company’s executive compensation program reflects a pay-for-performance philosophy. While the Company utilizes several performance measures to align executive compensation with Company performance (as described in greater detail in the Executive Compensation section of this proxy statement), not all of those Company measures are presented in the Pay versus Performance table. Moreover, the Company generally seeks to incentivize long-term performance, and therefore does not specifically align the Company’s performance measures with compensation that is actually paid (as computed in accordance with Item 402(v) of Regulation S-K) for a particular fiscal year. Compensation actually paid is influenced by numerous factors, including but not limited to the timing of new grant issuances and outstanding grant vesting, share price volatility during the fiscal year, our mix of short-term and long-term metrics, and many other factors. In accordance with Item 402(v) of Regulation S-K, the Company is providing the following descriptions of the relationships between information presented in the Pay versus Performance table.

Compensation Actually Paid and Cumulative Company TSR

The compensation actually paid to our PEO, as computed in accordance with the requirements of Item 402(v) of Regulation S-K, was $924,891, $497,718, and $1,106,384 for 2023, 2022, and 2021, respectively. The average amount of compensation actually paid to the NEOs as a group (excluding Mr. Murphy), as computed in accordance with Item 402(v) of Regulation S-K, was $646,314, $460,821, and $642,223 for 2023, 2022, and 2021, respectively. The TSR of the Company, assuming an initial fixed $100 investment and computed in accordance with the requirements of Item 402(v) of Regulation S-K, was $63, $39 and $75 for 2023, 2022, and 2021, respectively. Please see Note 5 above for additional information related to the computation of Company TSR.

Compensation Actually Paid and Company Net Income

The compensation actually paid to our PEO, as computed in accordance with the requirements of Item 402(v) of Regulation S-K, was $924,891, $497,718 and $1,106,384 for 2023, 2022, and 2021, respectively. The average amount of compensation actually paid to the NEOs as a group (excluding Mr. Murphy), as computed in accordance with Item 402(v) of Regulation S-K, was $646,314, $460,821 and $642,223 for 2023, 2022, and 2021 respectively. The Company’s net income, as computed in accordance with Item 402(v) of Regulation S-K and reflected in the Company’s audited financial statements for the applicable fiscal year, was $(7,349,360), $(4,469,498), and $(3,140,621) for 2023, 2022, and 2021 respectively. No “Big R” or “little r” restatements were made during fiscal year 2023.

32

Director Compensation

    The following table sets forth the cash compensation, as well as certain other compensation earned by each person who served as a non-employee director of IZEA during the year ended December 31, 2023:

Name	Fees Earned or Paid in Cash		Stock Awards		Total
Brian W. Brady (1)	$	40,500	$	60,000	$	100,500
John H. Caron (2)	$	43,500	$	60,000	$	103,500
Lindsay A. Gardner (3)	$	42,500	$	60,000	$	102,500
Daniel R. Rua (4)	$	53,500	$	60,000	$	113,500
Patrick J. Venetucci (5)	$	57,500	$	60,000	$	117,500

_______________

(1)In 2023, Mr. Brady received 26,304 shares of restricted stock originally valued at $60,000 upon issuance. The shares are granted quarterly, valued at $15,000 each, with the number of shares awarded calculated based on the stock price on the last trading day of each quarter. The value of these shares was expensed as the shares vested in equal monthly installments from January through December 2023. Mr. Brady also received cash compensation of $40,500 in accordance with the non-employee director compensation program effected in March 2013.

(2)In 2023, Mr. Caron received 26,304 shares of restricted stock originally valued at $60,000 upon issuance. The shares are granted quarterly, valued at $15,000 each, with the number of shares awarded calculated based on the stock price on the last trading day of each quarter. The value of these shares was expensed as the shares vested in equal monthly installments from January through December 2023. Mr. Caron also received cash compensation of $43,500 in accordance with the non-employee director compensation program effected in March 2013.

(3)In 2023, Mr. Gardner received 26,304 shares of restricted stock originally valued at $60,000 upon issuance. The shares are granted quarterly, valued at $15,000 each, with the number of shares awarded calculated based on the stock price on the last trading day of each quarter. The value of these shares was expensed as the shares vested in equal monthly installments from January through December 2023. Mr. Gardner also received cash compensation of $42,500 in accordance with the non-employee director compensation program effected in March 2013.

(4)In 2023, Mr. Rua received 26,304 shares of restricted stock originally valued at $60,000 upon issuance. The shares are granted quarterly, valued at $15,000 each, with the number of shares awarded calculated based on the stock price on the last trading day of each quarter. The value of these shares was expensed as the shares vested in equal monthly installments from January through December 2023. Mr. Rua also received cash compensation of $53,500 in accordance with the non-employee director compensation program effected in March 2013.

(5)In 2023, Mr. Venetucci received 26,304 shares of restricted stock originally valued at $60,000 upon issuance. The shares are granted quarterly, valued at $15,000 each, with the number of shares awarded calculated based on the stock price on the last trading day of each quarter. The value of these shares was expensed as the shares vested in equal monthly installments from January through December 2023. Mr. Venetucci also received cash compensation of $57,500 in accordance with the non-employee director compensation program effected in March 2013.

_________________

Effective September 6, 2024, the Board amended the compensation program for each serving non-employee director to receive the following compensation:

•An annual board retainer fee of $60,000 to be in restricted stock issued in $15,000 increments on the last day of each quarter and priced at fair market value, vesting immediately.

•A cash retainer fee of $35,000 per year.

•A standard fee of $20,000 per year paid out to the Chairman of the Board.

•A standard fee of $5,500 per year paid out to each Audit Committee member, except with regard to the Audit Committee Chair, who shall receive a fee of $15,000 per year.

•A standard fee of $4,500 per year paid out to each Compensation Committee member, except with regard to the Compensation Committee Chair, who shall receive a fee of $10,000 per year.

•A standard fee of $3,000 per year paid out to each Nominations & Corporate Governance Committee member, except with regard to the Nominations & Corporate Governance Committee Chair, who shall receive a fee of $5,500 per year.

•A standard fee of $4,500 per year paid out to each Strategy & Capital Allocation Committee member, except with regard to the Strategy and Capital Allocation Committee Chair, who shall receive a fee of $10,000 per year.

33

    Effective January 1, 2023, the Board amended the compensation program for each serving non-employee director to receive the following compensation:

•An annual board retainer fee of $60,000 to be in restricted stock issued in $15,000 increments on the last day of each quarter and priced at fair market value, vesting immediately.

•A cash retainer fee of $35,000 per year.

•A standard fee of $5,500 per year paid out to each Audit Committee member, except with regard to the Audit Committee Chair, who shall receive a fee of $15,000 per year.

•A standard fee of $4,500 per year paid out to each Compensation Committee member, except with regard to the Compensation Committee Chair, who shall receive a fee of $10,000 per year.

•A standard fee of $3,000 per year paid out to each Nominations & Corporate Governance Committee member, except with regard to the Nominations & Corporate Governance Committee Chair, who shall receive a fee of $5,500 per year.

Certain Relationships and Related Transactions

We review all transactions involving us in which any of our directors, director nominees, significant shareholders and executive officers and their immediate family members are participants to determine whether such person has a direct or indirect material interest in the transaction. All directors, director nominees and executive officers must notify us of any proposed transaction involving us in which such person has a direct or indirect material interest. Such proposed transaction is then reviewed by either the Board as a whole or the Audit Committee, which determines whether or not to approve the transaction. After such review, the reviewing body approves the transaction only if it determines that the transaction is in, or not inconsistent with, the best interests of our Company and our shareholders.

Certain Transactions

    On September 6, 2024, the Company entered into a cooperation agreement (the “Cooperation Agreement”) with GP Cash Management, Ltd., GP Investments, Ltd. (“GP Investments”), Rodrigo Boscolo and Antonio Bonchristiano (collectively with each of their affiliates and controlled associates, the “GP Parties”). Pursuant to the Cooperation Agreement, a payment of $145,000 in out-of-pocket fees and expenses was paid to the GP Parties. The GP Parties beneficially owned the company’s common stock as disclosed in “Security Ownership of Certain Beneficial Owners and Management.” The Cooperation Agreement provides for the appointment of Rodrigo Boscolo and Antonio Bonchristiano to the Board, the agreement to conduct a search for a gender diverse director candidate, establishment of a Strategy and Capital Allocation Committee, among other things.

Except for the above transaction, there have been no transactions since January 1, 2022 or any currently proposed transaction, in which the Company was or is to be a participant and the amount involved exceeded the lesser of $120,000 or 1% of the average of our total assets at year-end for the last two completed fiscal years, and in which any of our respective officers, directors, beneficial owners of more than 5% of our outstanding common stock or their family members had or will have a direct or indirect material interest.

HOUSEHOLDING OF PROXY MATERIALS

    To reduce costs and the environmental impact of the Annual Meeting, a single Notice of Internet Availability, or proxy statement and annual report, along with individual proxy cards, will be delivered in one envelope to certain stockholders having the same last name and address, and to individuals with more than one account registered with our transfer agent with the same address, unless contrary instructions have been received from an affected stockholder. Stockholders participating in householding will continue to receive separate proxy cards. If you are a registered stockholder and would like to enroll in this service or receive individual copies of this year’s and/or future proxy materials, please contact Broadridge Financial Solutions, Inc. 51 Mercedes Way, Edgewood, New York 11717; or contact our Corporate Secretary at 407-985-2935 or at 1317 Edgewater Drive, #1880, Orlando, Florida 32804. If you are a beneficial stockholder, you may contact the broker or bank where you hold the account.

34

STOCKHOLDER PROPOSALS AND NOMINATIONS

    We must receive proposals of stockholders to be considered for inclusion in the proxy statement and form of proxy relating to the 2025 Annual Meeting of Stockholders (the “2025 Annual Meeting”) no later than July 1, 2025. In addition, all such proposals will need to comply with all other requirements of Rule 14a-8 of the Exchange Act, which lists the requirements for the inclusion of stockholder proposals in company-sponsored proxy materials. Stockholder proposals must be delivered to our Corporate Secretary at 1317 Edgewater Drive, #1880, Orlando, Florida 32804.

In order for a stockholder proposal, including a nomination for election to the Board of Directors, to be submitted at a meeting of stockholders (but not included in our proxy statement), such proposal must be received by the Company’s Secretary at least 90 but not more than 120 days prior to the first anniversary of the preceding year’s annual meeting. Any stockholder proposal to be submitted at the 2025 Annual Meeting (but not included in our proxy statement) will not be considered timely unless the notice required by our Bylaws is delivered to the Secretary no earlier than the close of business on August 14, 2025 and no later than the close of business on September 13, 2025.

The stockholder’s notice, with respect to all stockholder proposals, must comply in all respects with Article I, Section 1.8 of the Company’s Bylaws, which requires, among other things, (i) a brief description of the business desired to be brought before the annual meeting, (ii) the text of the proposal or business, (iii) the reasons for conducting such business at the meeting; (iv) any material interest in such business of such stockholder and the beneficial owner, if any, on whose behalf the proposal is made, (v) the name and address, as they appear on the Company’s books, of the stockholder proposing such business, (vi) the number of shares of the Company stock held by such stockholder, (vii) a description of any agreement, arrangement or understanding made in connection with the proposal, (viii) a description of any agreement, arrangement or understanding that has been entered into by, or on behalf of, such stockholder and such beneficial owners, with respect to securities of the Company including the full amount of those securities, (ix) any agreement, arrangement or understanding with the effect or intent to mitigate loss to, manage risk or benefit of share price changes for, or increase or decrease the voting power of, such stockholder or such beneficial owner, with respect to securities of the Corporation, (x) any proxy, contract, arrangement, agreement understanding or relationship pursuant to which such stockholder or beneficial owner has a right to vote the shares of the Company’s common stock, (xi) any rights to dividends that the stockholder owns directly or beneficially that are separable from the underlying security, (xii) any interest in the Company’s securities held by a partnership in which such stockholder beneficially owns and interest in, (xiii) any performance-related fees that such stockholder is entitled to, (xiv) any direct or indirect interest of the stockholder in any contract with the Company, (xv) any material pending or threatened legal proceeding involving the Company in which the stockholder is a material participant, (xvi) any material relationships between the stockholder and officers or directors of the Company, (xvii) a representation that the stockholder is a holder of record of stock as of the date of their notice and intends to appear in person or by proxy at the annual meeting to bring their proposal and will be entitled to vote at the meeting, (xviii) a representation whether the stockholder or the beneficial owner, if any, intends or is part of a group which intends to solicit proxies or votes from stockholders in support of such proposal or nomination, (xix) a representation that the stockholder has complied with all applicable federal, state and other legal requirements in connection with such proposal including under Section 14 of the 1934 Act, and (xx) any other information relating to any proposed item of business reasonably required by the Company or its Bylaws.

The Company’s Bylaws requires additional information to be submitted with a stockholder notice with respect to director nominations, including as to each person whom the stockholder proposes to nominate for election as director, (1) such person’s name, age, business address, residence address and principal occupation or employment; (2) the class and number of shares that are held of record or are beneficially owned by such person, including any derivative securities and any agreement, arrangement or understanding made with respect to such stock or securities; (3) all information relating to such person that is required to be disclosed pursuant to Section 14(a) of the Exchange Act and the rules and regulations promulgated thereunder, (4) such person’s written consent to being named in the proxy statement as a nominee and to serving as a director if elected; (5) certain representations and agreements of such person as set forth in detail in the Bylaws; and (6) a description of all direct and indirect compensation and other material monetary agreements, arrangements and understandings, and any other material relationships that may be required to be disclosed pursuant to Item 404 of Regulation S-K if the stockholder making the nomination and any beneficial owner on whose behalf the nomination is made, if any, or any affiliate or associate thereof or person acting in concert therewith, were the “registrant” for purposes of such rule and the nominee were a director or executive officer of such registrant. To be eligible to be a nominee of any stockholder for election as a director, the proposed nominee must provide the Company’s Secretary with certain questionnaires and representations as set forth in Section 1.8.F of the Company’s Bylaws.

In addition, to comply with the universal proxy rules, shareholders who intend to solicit proxies in support of director nominees other than the company’s nominees must provide notice that sets forth the information required by both Rule 14a-19

35

under the Exchange Act and Section 1.8 of the Company’s Bylaws no earlier than the close of business on August 14, 2025 and no later than the close of business on September 13, 2025.

    Proxies for the 2025 Annual Meeting will confer discretionary authority to vote with respect to any stockholder proposals of which we do not receive notice at least 45 days prior to the anniversary of the date of mailing of the prior year’s proxy statement, without any discussion of such matter in the proxy statement. In connection with the 2025 Annual Meeting, if we do not receive notice of a stockholder proposal on or before September 14, 2025 we will be permitted to use our discretionary voting authority as outlined above.

DELINQUENT SECTION 16(A) REPORTS

    Section 16(a) of the Exchange Act requires the Company’s directors, executive officers, and persons who beneficially own more than 10% of its outstanding common stock to file initial reports of ownership with respect to the Company’s equity securities and reports of changes in such ownership with the SEC. SEC regulations require such persons to furnish the Company with copies of all Section 16(a) forms they file. Based solely upon the Company’s review of the copies of the reports, we believe that, all such reports that were required to be filed during the year ended December 31, 2023 were filed on a timely basis aside from those indicated below.

During the year ended December 31, 2023, (i) Ryan Schram filed a Form 4 with a reporting date of January 1, 2023 on May 9, 2023, reporting an award of restricted stock units, and filed a Form 4 with a reporting date of February 28, 2023 on March 3, 2023, reporting the vesting of installments of eleven awards of restricted stock units and corresponding withholding of shares to satisfy tax withholdings upon such vesting events; (ii) Peter Biere filed a Form 4 with a reporting date of February 28, 2023 on March 3, 2023, reporting the vesting of installments of four awards of restricted stock units and corresponding withholding of shares to satisfy withholdings upon such events; and (iii) Edward Murphy filed a Form 4 with a reporting date of February 28, 2023 on March 3, 2023 reporting the vesting of installments of ten awards of restricted stock units and corresponding withholding of shares to satisfy tax withholdings upon such vesting events.

OTHER BUSINESS

    The Board of Directors knows of no business that will be presented for consideration at the Annual Meeting other than those items stated above. If any other business should come before the Annual Meeting, votes may be cast pursuant to proxies in respect to any such business in the best judgment of the person or persons acting under the proxies.

36